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General Information 
All reactions were performed under a nitrogen or argon atmosphere in flame-dried apparatus. All reagents 
and chemicals were bought from chemical suppliers and used without further purification (unless 
otherwise stated). Tetrahydrofuran (THF) was distilled under nitrogen from sodium wire using 
benzophenone as an indicator. Triethylamine was stored over KOH. All solvents were removed under 
vacuum using a rotary evaporator. Pet.Ether indicates fractions of petroleum ether boiling at 40-60 °C. LDA 
was used as a solution in THF/heptane/ethylbenzene (2.0 M from sigma Aldrich) or prepared by General 
procedure 6. -78 °C, -40 °C and other low temperatures were reached using a Thermo Scientific Haake 
Immersion Cooler EK90. 
Thin layer chromatography (TLC) was performed using commercially available pre-coated plates 
(Macherey-Nagel alugram SIL G/UV254). Visualisation was Via UV light (at 254 nm) or by staining with 
phosphomolybdic acid or ‘Seebach’ dip (2.50 g phosphomolybdic acid hydrate, 1.00 g cerium (IV) sulphate 
tetrahydrate, 3.20 mL conc. H2SO4, 90.50 mL H2O) then heating. Flash column chromatography used 
chromatography grade silica, 60 Å particle size, 40-63 microns from Aldrich and compounds were loaded as 
saturated solutions in the correct solvents. 
Capillary melting points were determined on a Stuart Scientific melting point SMP 10 apparatus and are 
uncorrected. Optical rotations [α] 
 
 were recorded on an AA-100 polarimeter using a cell with a pathlength 
of 0.25 dm at 18-22 °C with the solvent and concentration (c) quoted in g/100 mL. 
Nuclear Magnetic Resonance (NMR) spectra (1H NMR and 13C NMR) were recorded on either Bruker 
Ultrashield 300 (Avance), 400 (Avance III or Avance III HD fitted with nitrogen cooled prodigy cold probe) or 
500 MHz (Avance II) spectrometers. The residual solvent peak for CDCl3 (δH: 7.26 ppm; δC: 77.16 ppm), 
CD3OD (δH: 3.31 ppm; δC: 49.00 ppm) were used as internal standards when assigning NMR spectra.
1 
Chemical shifts, δ, are quoted in parts per million (ppm) downfield of trimethylsilane. Coupling constants (J) 
are reported to the nearest 0.1 Hz. The splitting patterns for the spectra assignment are abbreviated to: 
singlet (s), doublet (d), triplet (t), quartet (q), quintet (quin.), septet (sept.), multiplet (m), broad (br.) and 
some as a combination of these. 
Infrared spectra were recorded on a Thermo Scientific iD5 ATR, FT-IR spectrometer, using a Universal ATR 
accessory for sampling, with absorption of most relevance quoted as νin cm-1 and the samples were run as 
solids or evaporated films.  
Low and high resolution mass spectra were recorded mainly by staff at the University of Manchester. ESI 
were recorded on a Micromass Platform II or Waters QTOF; high resolution mass spectra (HRMS) were 
recorded on a Thermo Finnigan MAT95XP mass spectrometer or Waters. 
 
                                                          
1
 Gottlieb, H. E.; Kotlyar, V.; Nudelman, A. J. Org. Chem. 1997, 62, 7512 
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General Experimental Procedure 
 
General procedure 1: Urea formation from carbamoyl chloride (9, 10, 17 and 18) 
The pyridine-derived amine 5 or 6 (1.0 equiv), anhydrous acetonitrile (0.4 M) and triethylamine (1.1 equiv) 
were combined and stirred for 10 minutes under nitrogen at room temperature. The carbamoyl chloride 
(1.0 equiv) was added. The reaction mixture was heated to reflux overnight. The reaction mixture was 
cooled to room temperature and quenched with saturated aqueous NaHCO3 solution. The organic layer 
was removed and the aqueous layer was extracted twice with CH2Cl2. The combined organic layers were 
washed with NH4Cl and brine and dried over MgSO4, and the solvent was removed under reduced pressure. 
The crude product was purified by flash column chromatography. 
 
General procedure 2: Methylation of ureas (7 and 8) 
A – in THF as a solvent 
The urea derivative 17 (1.0 equiv) was dissolved in anhydrous THF (0.4 M) and methyl iodide (1.2 eq) was 
added. The solution was cooled to 0 °C before sodium hydride (1.3 equiv, (60% suspension in oil)) was 
added. The reaction was allowed to warm to room temperature, monitored by TLC and worked up when 
complete (between 2 hours and overnight). The reaction mixture was quenched with MeOH and saturated 
aqueous NH4Cl solution was added before being extracted three times with ethyl acetate. The combined 
organic extracts were washed twice with water and once with brine then dried over MgSO4 and 
concentrated in vacuo. The crude product was purified by flash column chromatography. 
 
B – in DMF as a solvent 
To a solution of the urea derivative 18 (1.0 equiv) in anhydrous DMF (0.1 M) at 0 °C was added sodium 
hydride (1.5 equiv, (60% suspension in oil)). The reaction mixture was stirred at 0 °C for 15 min, then 
methyl iodide was added dropwise. The reaction was allowed to warm to room temperature, monitored by 
TLC and worked up when complete (1 h - overnight). The reaction mixture was quenched with H2O. The 
solvent was evaporated in vacuo. The residue was dissolved in CH2Cl2 and extracted from H2O three times. 
The combined organic phase was washed three times with 5% aqueous LiCl solution and once with brine, 
then dried over MgSO4 and concentrated in vacuo. The crude product was purified by flash column 
chromatography. 
 
General procedure 3: LDA-mediated rearrangement of ureas (11, 13, 14 and 15) 
A solution of a pyridine derivative (1.0 equiv) in anhydrous THF (0.1 M) was cooled to -78 °C and LDA (2.5 
equiv) was added dropwise. After stirring at -78 °C for 3-18 h the reaction mixture was quenched with 
NH4Cl or MeOH. The mixture was extracted three times with ethyl acetate, dried over MgSO4, and 
concentrated under reduced pressure. The crude product was purified by flash column chromatography. 
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General procedure 4: Hydrolysis of ureas (12 and 16) 
A solution of a pyridine derivative (1.0 equiv), aqueous NaOH (2.0 M) and EtOH (1.2 M) was microwaved at 
130 °C for 3 h. The reaction mixture was concentrated and extracted with ethyl acetate, dried over MgSO4, 
and concentrated under reduced pressure. 
 
General procedure 5: Amine protection 
To a solution of aminopyridine (1.0 equiv) in methanol (0.2 M) were added p-anisaldehyde (1.05 equiv) and 
NaOAc (2.05 quiv) and stirred at room temperature for 15 minutes. The reaction mixture was cooled to 0 °C 
and NaBH(OAc)3 (2.05 equiv) was added portionwise. After stirring for 18 h at room temperature, the 
solvent was evaporated. The crude mixture was dissolved in EtOAc, washed (with NaHCO3 and brine), dried 
over MgSO4, and concentrated under reduced pressure. 
 
General procedure 6: Preparation of LDA 
To a cooled solution of distilled diisopropylamine (1.0 equiv.) in THF (0.75 M) at 0 °C was added n-BuLi (1.0 
equiv.) The reaction mixture was stirred at 0 °C for 20 min before immediate use. 
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For clarity, compounds 6d, 6e, 17a-h and 18a-c were not included in the main text, but were isolated and 
purified before 7a-h were made. 
 
 
 
Effect of the temperature reaction on the er (HPLC traces of 14b in HPLC part) 
 
 
 
- Conditions A : LDA (2.5 equiv) in THF at -78 °C for 18 hours =>er > 99:1 
- Conditions B : LDA (2.5 equiv) in THF at -40 °C for 18 hours => er = 98:2 
- Conditions C : LDA (2.5 equiv) in THF at room temperature for 18 hours => er = 86:4 
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Synthetic procedures 
 
 (R,E)-2-methyl-N-(1-(pyridin-3-yl)ethylidene)propane-2-sulfinamide ((R)-1)2 
 
Procedure by Chellucci et al. was followed.2 A solution of 1-(pyridin-3-yl)ethan-1-one (4.54 mL, 41.27 
mmol), (R)-(+)-2-methylpropane-2-sulfinamide (5.0 g, 41.27 mmol) and Ti(OEt)4 (18.8 g, 82.6 mmol) in 
CH2Cl2 (165 mL) was refluxed for 72 h. The reaction mixture was allowed to cool down to room 
temperature, then it was concentrated in vacuo. The residue was dissolved in EtOAc (200 mL). The solution 
was stirred vigorously and brine was added (150 mL) slowly. After 15 min, the mixture was filtered over a 
pad of Celite, and the filter cake was washed with copious amounts of EtOAc. The filtrate was dried over 
MgSO4. The solvent was evaporated in vacuo  and the crude was purified by flash column chromatography 
(SiO2, 99:1 to 95:5 CH2Cl2:MeOH) to give (R)-1 as yellow oil (5.73 g, 61%). 
1H NMR (400 MHz, CDCl3) δ = 
9.14-9.03 (1H, m, =CH), 8.71 (1H, dd, J = 4.8, 1.7, =CH), 8.16 (1H, ddd, J = 8.1, 2.4, 1.6, =CH), 7.38 (1H, ddd, J 
= 8.0, 4.8, 0.9, =CH), 2.80 (3H, s, N=C-CH3), 1.33 (9H, s, C(CH3)3). 
13C NMR (101 MHz, CDCl3) δ = 174.4 (C=N), 
152.4 (=CH), 148.8 (=CH), 134.6 (=CH), 134.4 (=C), 123.5 (=CH), 58.0 (C(CH3)3), 22.7 (C(CH3)3), 19.8 (N=C-
CH3). 
 
(R,E)-2-methyl-N-(pyridin-3-ylmethylene)propane-2-sulfinamide ((R)-2)3 
 
Literature procedure was followed.3 To a solution of 3-pyridinecarboxaldehyde (6.00 mL, 63.58 mmol) and 
(R)-(+)-2-methylpropane-2-sulfinamide (7.72 g, 63.58 mmol) in anhydrous THF was added Ti(OEt)4 (29.00 g, 
127.2 mmol). The reaction mixture turned instantly orange and was stirred at room temperature overnight. 
Brine (100 mL) was added to the vigorously stirred reaction mixture. The suspension was filtered through a 
pad of Celite. The filter cake was washed with copious amount of EtOAc. The organic phase was washed 
with brine, dried over MgSO4 and evaporated in vacuo. The crude was purified by flash column 
chromatography (SiO2, 60:40 to 100:0 EtOAc:Petrol) to give (R)-2 as yellow oil (5.73 g, 61%).
1H NMR (400 
MHz, CDCl3) δ = 9.03 (1H, dd, J = 2.1, 0.9, =CH), 8.74 (1H, dd, J = 4.8, 1.7, =CH), 8.65 (1H, s, =CH), 8.17 (1H, 
                                                          
2
 Data in agreement with the literature (Reference: Chelucci, G.; Baldino, S.; Chessa, S.; Pinna, G. A.; Soccolini, F.; Tetrahedron: 
Asymmetry, 2006, 17, 3163) 
3 Data in accordance with the literature (Liu, G.; Cogan, D. A.; Owens, T. D.; Tang, T. P.; Ellman, J. A. J. Org. Chem., 1999, 64, 1278) 
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dt, J = 8.0, 1.9, =CH), 7.46 – 7.40 (1H, m, =CH), 1.28 (9H, s, (C(CH3)3)). 
13C NMR (126 MHz, CDCl3) δ = 160.5 
(N=CH), 153.0 (=CH), 151.1 (=CH), 135.9 (=CH), 129.9 (=C), 124.1 (=CH), 58.3 (C(CH3)3, 22.8 (C(CH3)3). 
 
 (R)-2-methyl-N-((S)-1-(pyridin-3-yl)ethyl)propane-2-sulfinamide (3a, dr 98:2)2 
 
Procedure by Chellucci et al. was followed.2 To a solution of 1 (2.01 g, 8.96 mmol) in anhydrous THF (90 mL) 
at -78 °C was added dropwise tri-sec-butylborohydride (L-Selectride) (1.0 M solution in THF, 8.96 mL, 8.96 
mmol). The reaction mixture was stirred at -78 °C overnight, then allowed to warm up to room 
temperature, quenched with saturated aqueous solution of NH4Cl. The organic and aqueous phases were 
separated, the aqueous layer was extracted twice with EtOAc. The combined organic extracts were washed 
with brine, dried over MgSO4 and evaporated in vacuo to yield a crude brown oil, which was purified by 
flash column chromatography (SiO2, 95:5 CH2Cl2:MeOH) to yield 3a as a yellow oil (1.46 g, 72%, >95:5 d.r. 
(RS,S):(R,R)). The exact diastereomeric ratio (d.r. 98:2) was later confirmed by er of 7b and 7c, which were 
determined by chiral HPLC. 
1H NMR (500 MHz, CDCl3) δ = 8.58 (1H, d, J = 2.3, =CH), 8.50 (1H, dd, J = 4.8, 1.6, =CH), 7.62 (1H, dt, J = 7.9, 
2.0, =CH), 7.25 (1H, dd, J = 7.9, 4.8, =CH), 4.59 (1H, qd, J = 6.7, 3.4, CH-CH3), 3.40 (1H, d, J = 2.7, NH), 1.55 
(3H, d, J = 6.7, CH-CH3), 1.18 (9H, s, C(CH3)3). 
13C NMR (126 MHz, CDCl3) δ = 149.0 (=CH), 148.8 (=CH), 138.80 
(=C), 134.6 (=CH), 123.5 (=CH), 55.8 (C(CH3)3), 52.5 (CH-CH3), 24.9 (CH-CH3), 22.5 (C(CH3)3). HRMS (ESI
+): m/z 
calcd for C11H19N2OS [M+H]
+ 227.1213, found 227.1213. 
 
(R)-2-methyl-N-((S)-1-(pyridin-3-yl)ethyl)propane-2-sulfinamide (3a, dr  73:27)2 
 
To a solution of 2 (6.00 g, 28.54 mmol) in CH2Cl2 (140 mL) at -40 °C was added dropwise methylmagnesium 
bromide (3.0 M solution in Et2O, 19.1 mL, 57.12 mmol). The reaction mixture was stirred overnight at  
-40 °C, then warmed up to room temperature, quenched with saturated aqueous solution of NH4Cl . The 
organic and aqueous phases were separated, the aqueous layer was extracted twice with EtOAc. The 
combined organic extracts were washed with brine, dried over MgSO4 and evaporated in vacuo to give a 
crude mixture of diastereoisomers 3a (d.r. 73:27) that was used without further purification. 1H NMR (500 
MHz, CDCl3) δ = 8.62-8.59 (1H, m, =CH, major and minor isomer), 8.55 (0.27H, dd, J = 4.9, 1.8, =CH, minor 
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isomer), 8.53 (0.73H, dd, J = 4.8, 1.7, =CH, major isomer), 7.68 (0.27H, dt, J = 7.9, 2.0, =CH, minor isomer), 
7.64 (0.73H, dt, J = 7.9, 2.0 Hz, =CH, major isomer), 7.31 – 7.24 (1H, m, =CH, major and minor isomer), 4.66 
– 4.54 (1H, m, CH-CH3, major and minor isomer), 3.42 (0.27H, d, J = 2.9, NH, minor isomer), 3.34 (0.73H, d, J 
= 3.4, major isomer), 1.57 (2.19H, d, J = 6.7, CH-CH3, major isomer), 1.55 (0.81H, d, J = 6.7, CH-CH3, minor 
isomer), 1.24 (2.43H, s, C(CH3)3, minor isomer), 1.20 (6.57H, s, C(CH3)3, major isomer). 
 
(R)-2-methyl-N-((R)-2-phenyl-1-(pyridin-3-yl)ethyl)propane-2-sulfinamide (RS,R-3b)
4 and (R)-2-methyl-N-
((S)-2-phenyl-1-(pyridin-3-yl)ethyl)propane-2-sulfinamide (RS,S-3b)) 
 
To a solution of 2 (3.46 g, 16.45 mmol) in CH2Cl2 (97 mL) at -40 °C was added dropwise benzylmagnesium 
chloride (2.0 M solution in THF, 16.5 mL, 32.90 mmol). The reaction mixture was stirred overnight at -40 °C, 
then warmed up to room temperature, quenched with saturated aqueous solution of NH4Cl . The organic 
and aqueous phases were separated, the aqueous layer was extracted twice with EtOAc. The combined 
organic extracts were washed with brine, dried over MgSO4 and evaporated in vacuo to give a crude 
mixture of diastereoisomers (72:28 ratio of (RS,R)-3b to (RS,S)-3b determined by 
1H NMR) that was 
separated by flash column chromatography (SiO2, EtOAc, then  90:10 CH2Cl2:MeOH) to yield (RS,R)-3b as a 
yellow oil (3.21 g, 64%) and (RS,S)-3b as a white solid (0.92 g, 19%). (RS,R)-3b: Rf 0.1 (EtOAc). 
1H NMR (500 
MHz, CDCl3) δ =  8.45 (1H, d, J = 2.3, =CH), 8.41 (1H, dd, J = 4.8, 1.6, =CH), 7.51 (1H, dt, J = 8.0, 2.0, =CH), 
7.22 – 7.04 (4H, m, 4 x =CH), 6.98 – 6.92 (2H, m, 2 x =CH), 4.55 (1H, td, J = 7.2, 4.9, CHNH), 3.80 (1H, d, J = 
5.1, CHNH), 3.26 (1H, dd, J = 13.5, 6.9, CHAHBBn), 2.95 (1H, dd, J = 13.5, 7.5, CHAHBBn), 1.07 (9H, s, C(CH3)3). 
13C NMR (126 MHz, CDCl3) δ = 148.9 (=CH), 148.7 (=CH), 137.6 (=C), 136.7 (=C), 135.5 (=CH), 129.7 (=CH), 
128.5 (=CH), 126.9 (=CH), 123.6 (=CH), 59.1 (CH-Bn), 56.4 (C(CH3)3), 43.5 (CH2Ph), 22.6 (C(CH3)3). 
(RS,S)-3b: Rf 0.3 (EtOAc). 
1H NMR (500 MHz, CDCl3) δ = 8.52 – 8.42 (2H, m, 2 x =CH), 7.49 (1H, dt, J = 7.9, 2.0, 
=CH), 7.26 – 7.12 (4H, m, 4 x =CH), 7.05 – 6.99 (2H, m, 2 x =CH), 4.62 (1H, ddd, J = 8.4, 6.5, 2.3, CHNH), 3.55 
(1H, d, J = 2.3, CHNH), 3.10 – 2.92 (2H, m, CH2Ph), 1.08 (9H, s, (C(CH3)3). 
13C NMR (126 MHz, CDCl3)  
δ = 149.5 (=CH), 149.2 (=CH), 136.9 (=C), 136.0 (=C), 135.7 (=CH), 129.6 (=CH), 129.0 (=CH), 127.4 (=CH), 
123.4 (=CH), 57.3 (CH-Bn), 55.9 (C(CH3)3), 45.3 (CH2Ph), 22.6 (C(CH3)3). Mp = 112-114 °C. IR (film, cm
-1): νmax 
= 3194, 3028, 1578, 1454, 1428, 1363, 1057. []  
 
 = -20 (c = 1.00; CH2Cl2). HRMS (ESI
+): m/z calcd for 
C17H23N2OS [M+H]
+ 303.1526, found 303.1525. 
                                                          
4
 Data for (RS,R)-3b in accordance with the literature (Reference: Buesking, A. W.; Baguley, T. D.; Ellman, J. A.; Org. Lett., 2011, 13, 
964} 
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 (S)-1-(pyridin-3-yl)ethan-1-amine (5a, er 98:2)5 
 
To a solution of 3aa (4.50 g, 19.88 mmol) in anhydrous MeOH (100 mL) was added HCl in dioxane (4.0 M, 
24.9 mL, 99.4 mmol). Reaction mixture was stirred for 2 h, evaporated in vacuo and the solid residue was 
washed with Et2O and then dissolved in 1 M aqueous KOH solution until pH was higher than 10. The 
aqueous phase was extracted three times with EtOAc. The combined organic extract was dried over MgSO4 
and evaporated in vacuo to give 5a (er 98:2) as brown oil (1.60 g, 66%) that was used without further 
purification. 
1H NMR (400 MHz, CDCl3) δ = 8.53 (1H, t, J = 1.9, =CH), 8.48 – 8.37 (1H, m, =CH), 7.70 – 7.60 (1H, m, =CH), 
7.27 – 7.13 (1H, m, =CH), 4.12 (1H, q, J = 6.7, CH-CH3), 1.50 (2H, s, NH2), 1.34 (3H, d, J = 6.6, CH-CH3); 
13C 
NMR (101 MHz, CDCl3) δ = 148.6 (=CH), 148.2 (=CH), 142.7 (=C), 133.4 (=CH), 123.6 (=CH), 49.2 (CH-CH3), 
25.8 (CH-CH3). HRMS (ESI
+): m/z calcd for C7H11N2 [M+H]
+ 123.0917, found 123.0920. 
 
(S)-1-(pyridin-3-yl)ethan-1-amine (5a, er 73:27) 
 
Same procedure and data as for 5a (er 98:2), (3a, dr 73:27) used as the starting material instead. 
 
 
 (R)-2-phenyl-1-(pyridin-3-yl)ethan-1-amine (5b)5 
 
To a solution of (RS,R)-3b (5.20 g, 17.19 mmol) in anhydrous MeOH (85 mL) was added HCl in dioxane (4.0 
M, 21.5 mL, 86.0 mmol). Reaction mixture was stirred for 2 h, evaporated in vacuo and the solid residue 
was washed with Et2O and then dissolved in 1 M aqueous KOH solution until pH was higher than 10. The 
aqueous phase was extracted three times with EtOAc. The combined organic extract was dried over MgSO4 
and evaporated in vacuo to give 5b as brown oil (2.90 g, 85%) that was used without further purification.  
1H NMR (400 MHz, CDCl3) δ =  8.50 (1H, d, J = 2.2, =CH), 8.44 (1H, dd, J = 4.8, 1.7, =CH), 7.63 (1H, ddd, J = 
7.9, 2.3, 1.6, =CH), 7.29 – 7.12 (4H, m, 4 x =CH), 7.10 – 7.06 (2H, m, 2 x =CH), 4.18 (1H, dd, J = 8.7, 5.2, CH-
CH2), 2.92 (1H, dd, J = 13.4, 5.2, CH-CHAHB), 2.78 (1H, dd, J = 13.3, 8.7, CH-CHAHB), 1.50 (2H, s, NH2). 
13C NMR 
                                                          
5
 The data are in agreement with the literature (Reference: Baucom, K. D.; Guram, A. S.; Borths, C. J. Synlett, 2015, 26, 201). 
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(101 MHz, CDCl3) δ = 148.8 (2 x =CH), 140.8 (=C) , 138.3 (=C), 134.2 (=CH), 129.5 (=CH), 128.7 (=CH), 126.8 
(=CH), 123.5 (=CH), 55.4 (N-CH-CH2), 46.4 (N-CH-CH2). HRMS (ESI
+): m/z calcd for C13H15N2 [M+H]
+ 199.1230, 
found 199.1230. 
 
(S)-N-(4-methoxybenzyl)-1-phenyl-1-(pyridin-3-yl)ethan-1-amine (5c) 
 
Following General procedure 5, aminopyridine 5a, er 73:27  (2.075 g, 16.99 mmol), p-anisaldehyde (2.17 
mL, 17.83 mmol), NaOAc (2.86 g, 34.82 mmol) and NaBH(OAc)3 (7.38 g, 34.82 mmol) in MeOH (77 ml) gave 
after purification by flash column chromatography (SiO2, 95:5 CH2Cl2:MeOH) 5c as an oil (2.27 g, 55%). 
1H 
NMR (500 MHz, CDCl3) δ = 8.57 (1H, d, J = 2.2, =CH), 8.51 (1H, dd, J = 4.8, 1.7, =CH), 7.73 (1H, dt, J = 8.0, 2.0, 
=CH), 7.30 – 7.24 (1H, m, =CH), 7.20 – 7.16 (2H, m, 2 x =CH), 6.87 – 6.81 (2H, m, 2 x =CH), 3.84 (1H, q, J = 
6.6, CH-CH3), 3.79 (3H, s, OCH3), 3.58 (1H, d, J = 13.0, NHCHAHB), 3.53 (1H, d, J = 13.0, NHCHAHB), 1.68 (1H, 
br s, NH), 1.37 (3H, d, J = 6.6, CH-CH3). 
13C NMR (126 MHz, CDCl3) δ = 158.8 (=C), 149.2 (=CH), 148.7 (=CH), 
140.8 (=C), 134.4 (=CH), 132.4 (=C), 129.4 (=CH), 123.7 (=CH), 114.0 (=CH), 55.4 (OCH3), 55.2 (CH-CH3), 51.2 
(NH-CH2), 24.5 (CH-CH3). []
  
 
 = -31.7 (c = 1.00; CH2Cl2). IR (film, cm
-1): νmax = 3357, 2930, 1365, 1168. HRMS 
(ESI+): m/z calcd for C15H19N2O [M+H]
+ 243.1492, found 243.1497. 
 
[(4-Methoxyphenyl)methyl][(1S)-1-(pyridin-2-yl)ethyl]amine (6d) 
 
Following General procedure 5, aminopyridine 6a (440 mg, 3.60 mmol), p-anisaldehyde (0.46 ml), NaOAc 
(605 mg) and NaBH(OAc)3 (1.56 g) in MeOH (16.4 ml) gave 6d as an oil (477 mg, 55%). 
1H NMR (400 MHz, 
CDCl3) δ = 8.63-8.54 (1H, m, =CH), 7.65 (1H, td, J = 7.7 and 1.8, =CH), 7.34 (1H, d, J = 7.8, =CH), 7.24-7.20 
(2H, m, 2 x =CH), 7.16 (1H, ddd, J = 14.3, 4.9 and 1.1, =CH), 6.90-6.77 (2H, m, 2 x =CH), 3.90 (1H, q, J = 6.7, 
NCHCH3), 3.79 (3H, s, OCH3), 3.57 (2H, AB pattern, J = 12.9, Δν = 9.0, NHCH2), 1.88 (1H, brs, NH), 1.39 (3H, d, 
J = 6.7, CHCH3). 
13C NMR (100 MHz, CDCl3) δ = 164.8 (=C), 158.6 (=C), 149.5 (=CH), 136.7 (=CH), 132.7 (=C), 
129.5 (=CH), 122.0 (=CH), 121.4 (=CH), 113.8 (2 x =CH), 58.7 (NCH), 55.4 (OCH3), 51.3 (CH2), 23.1 (CH3). []
  
 
 
= -159 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 2975, 1214, 1041, 748. HRMS (ESI
+): m/z calcd for C15H19N2O 
[M+H]+ 243.1419, found 243.1495. 
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[(4-Methoxyphenyl)methyl][(1S)-1-(pyridin-2-yl)but-3-en-1-yl]amine (6e) 
N
NH
OCH3  
Following General procedure 5, aminopyridine 6c (200 mg, 1.35 mmol), p-anisaldehyde (0.17 ml), NaOAc 
(227 mg) and NaBH(OAc)3 (0.59 mg) in MeOH (6.13 ml) gave 6e as an oil (90 mg, 25%). 
1H NMR (400 MHz, 
CDCl3) δ = 8.63-8.51 (1H, m, =CH), 7.66 (1H, td, J = 7.6 and 1.8, =CH), 7.37 (1H, d, J = 7.8, =CH), 7.23-7.13 
(3H, m, 3 x =CH), 6.88-6.79 (2H, m, 2 x =CH), 5.79-5.65 (1H, m, CH2=CHCH2), 5.10-4.97 (1H, m, CH2=CH), 3.82 
(1H, dd, J = 7.7 and 5.9, NHCHCH2), 3.79 (3H, s, OCH3), 3.61 (1H, d, J = 12.9, NHCHAHB), 3.51 (1H, d, J = 13.0, 
NHCHAHB), 2.63-2.35 (2H, m, CHCH2CH=), 1.92 (1H, brs, NH). 
13C NMR (100 MHz, CDCl3) δ = 163.4 (=C), 
158.7 (=C), 149.5 (=CH), 136.4 (=CH), 135.4 (=CH), 132.7 (=C), 129.4 (=CH), 122.1 (=CH), 122.0 (=CH), 117.6 
(=CH2), 113.8 (=CH), 63.0 (NCH), 55.4 (OCH3), 51.3 (CH2), 41.7 (CH2). []
  
 
 = -64 (c = 1.00; CHCl3). IR (film, cm
-
1): νmax = 3010, 2957, 1639, 1245, 1037, 750. HRMS (ESI
+): m/z calcd for C17H21N2O [M+H]
+ 269.1648, found 
269.1650. 
 
- Urea formation 
 
(S)-1-methyl-1-phenyl-3-(1-(pyridin-3-yl)ethyl)urea (17a) 
 
Following General procedure 1, N-methyl-N-phenyl carbamoyl chloride (416 mg, 2.456 mmol, 1.2 eq.),  
3-pyridine 5a (er 98:2) (250 mg, 2.036 mmol, 1.0 eq.) and Et3N (570 μl, 4.072 mmol, 2.0 eq.) in acetonitrile 
(20.0 ml) gave after 20 h heating at reflux a crude product that was purified by flash column 
chromatography (SiO2, 99:1 to 97:3 CH2Cl2:MeOH) to obtain 17a as a brown oil (239 mg, 46%). Rf 0.21 (95:5 
CH2Cl2:MeOH). 
1H NMR (400 MHz, CDCl3) δ = 8.50 (1H, d, J = 2.3, =CH), 8.47 (1H, dd, J = 4.8, 1.6, =CH), 7.54 
(1H, dt, J = 7.9, 1.8, =CH), 7.47 – 7.42 (2H, m, 2 x =CH), 7.36 – 7.30 (1H, m, =CH), 7.28 – 7.24 (2H m, 2 x =CH), 
7.22 (ddd, J = 7.9, 4.8, 0.7 Hz, 1H, =CH), 5.03 (quin, J = 7.1 Hz, 1H, NHCHCH3), 4.54 (d, J = 7.2 Hz, 1H, 
NHCHCH3), 3.25 (s, 3H, NCH3), 1.36 (d, J = 7.0 Hz, 3H, NHCHCH3). 
13C NMR (126 MHz, CDCl3) δ = 156.4 (C=O), 
148.5 (=CH), 147.9 (=CH), 143.3 (=C), 140.0 (=C), 133.9 (=CH), 130.4 (=CH), 127.7 (=CH), 127.5 (=CH), 123.5 
(=CH), 48.3 (NHCHCH3), 37.4 (NCH3), 22.5 (NHCHCH3). []
  
 
 = +90 (c = 1.00; CH2Cl2). IR (film, cm
-1): νmax = 
3327, 2979, 1650, 1495, 1346. HRMS (ESI+): m/z calcd for C15H18N3O [M+H]
+ 256.1444, found 256.1447. 
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(S)-1,3-dimethyl-3-phenyl-1-(1-(pyridin-3-yl)ethyl)urea (7a) 
  
Following general procedure 2B, urea 17a (193 mg, 0.715 mmol), NaH (43 mg, 1.073 mmol), MeI (53 μL, 
0.858 mmol) in DMF (10.0 ml) gave after 2.5 h of stirring at room temperature a crude product that was 
purified by flash column chromatography (SiO2, 99:1 to 97:3 CH2Cl2:MeOH), to obtain 7a as a yellow oil (173 
mg, 85%). Rf 0.25 (95:5 CH2Cl2:MeOH). 
1H NMR (400 MHz, CDCl3) δ = 8.52 (1H, d, J = 2.3, =CH), 8.49 (1H, dd, 
J = 4.8, 1.4, =CH), 7.66 – 7.58 (1H, m, =CH), 7.37 – 7.29 (2H, m, 2 x =CH), 7.24 (1H, ddd, J = 7.9, 4.9, 0.7, 
=CH), 7.15 – 7.07 (3H, m, 3 x =CH), 5.57 (1H, q, J = 7.1, NCHCH3), 3.25 (3H, s, CH3N-C=CH), 2.21 (3H, s, 
CH3NCHCH3), 1.45 (3H, d, J = 7.1, NCHCH3). 
13C NMR (126 MHz, CDCl3) δ = 162.3 (C=O), 149.0 (=CH), 148.6 
(=CH), 147.0 (=C), 136.7 (=C), 135.2 (=CH), 129.7 (=CH), 125.1 (=CH), 124.6 (=CH), 123.4 (=CH), 52.3 
(NCHCH3), 40.4 (CH3NCHCH3), 31.1 (CH3NC=CH), 15.6 (NCHCH3). []
  
 
 = -10 (c = 1.00; CH2Cl2). IR (film, cm
-1): 
νmax = 2973, 1637, 1439, 1338, 1119, 760, 698.  
 
 
(S)-1-(4-fluorophenyl)-1-methyl-3-(1-(pyridin-3-yl)ethyl)urea (17b) 
 
Following General procedure 1, N-methyl-N-(4-fluorophenyl) carbamoyl chloride (461 mg, 2.456 mmol, 1.2 
eq.), 3-pyridine 5a (er 98:2) (250 mg, 2.036 mmol, 1.0 eq.) and Et3N (570 μl, 4.072 mmol, 2.0 eq.) in 
acetonitrile (20.0 ml) gave after 20 h heating at reflux a crude product that was purified by flash column 
chromatography (SiO2, 99:1 to 97:3 CH2Cl2:MeOH) to yield 17b as a yellow oil (261 mg, 47%). Rf 0.28 (95:5 
CH2Cl2:MeOH). 
1H NMR (400 MHz, CDCl3) δ =  8.58 – 8.41 (2H, m, 2 x =CH), 7.50 – 7.44 (1H, m, =CH), 7.35 – 
7.03 (5H, m, 5 x =CH), 5.01 (1H, quint, J = 7.1, NHCHCH3), 4.44 (1H, d, J = 6.8, NHCHCH3), 3.21 (3H, s, NCH3), 
1.37 (3H, d, J = 7.0, NHCHCH3). 
13C NMR (101 MHz, CDCl3) δ = 161.7 (d, 
1JCF = 248.3 Hz, =CF), 156.4 (C=O), 
148.6 (=CH), 147.9 (=CH), 139.9 (=C-CHCH3), 139.2 (d, 
4JCF = 3.4 Hz, N-C=CH), 133.8 (=CH), 129.4 (d, 
3JCF = 8.7 
Hz, =CH), 123.5 (=CH), 117.3 (d, 2JCF = 22.6 Hz, =CH), 48.4 (NHCHCH3), 37.6 (NCH3), 22.5 (NHCHCH3). []
  
 
 = 
+90 (c = 1.00; CH2Cl2). IR (film, cm
-1): νmax = 3326, 2976, 1649, 1507, 1220, 843. HRMS (ESI
+): m/z calcd for 
C15H16N3OFNa [M+Na]
+ 296.1170, found 296.1156. 
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((S)-1-(4-fluorophenyl)-1,3-dimethyl-3-(1-(pyridin-3-yl)ethyl)urea (7b) 
 
Following general procedure 2B, urea 17b (223 mg, 0.817 mmol), NaH (49 mg, 1.226 mmol), MeI (61 μL, 
0.981 mmol) in DMF (12.0 ml) gave after 3 h of stirring at room temperature a crude product that was 
purified by flash column chromatography (SiO2, 99:1 to 97:3 CH2Cl2:MeOH), to yield 7b as a yellow oil (186 
mg, 79%). Rf 0.29 (95:5 CH2Cl2:MeOH). 
1H NMR (400 MHz, CDCl3) δ = 8.59 – 8.42 (1H, m, 2 x =CH), 7.66 – 
7.54 (1H, m, =CH), 7.27 – 7.21 (2H, m, 2 x =CH), 7.11 – 6.98 (3H, m, 3 x =CH), 5.55 (1H, q, J = 7.1, NCHCH3), 
3.20 (3H, s, CH3NC=CH), 2.22 (3H, s, CH3NCHCH3), 1.45 (3H, d, J = 7.1, NCHCH3).  
13C NMR (126 MHz, CDCl3) δ = 162.3 (C=O), 160.0 (d, 
1JCF = 245.3 Hz, =CF), 149.0 (=CH), 148.7 (=CH), 143.1 
(d, 4JCF = 3.4 Hz = 3.0 Hz, N-C=CH), 136.6 (=C-CHCH3), 135.1 (=CH), 126.4 (d, 
3JCF = 8.1 Hz, =CH), 123.4 (=CH), 
116.5 (d, 2JCF = 22.6 Hz, =CH), 52.4 (NCHCH3), 40.8 (CH3NCHCH3), 31.1 (CH3NC=CH), 15.7 (NCHCH3). []
  
 
 = -
10 (c = 1.00; CH2Cl2). IR (film, cm
-1): νmax = 2923, 1639, 1507, 1331, 1218, 1120, 716. HRMS (ESI
+): m/z calcd 
for C16H19N3OF [M+H]
+ 288.1507, found 288.1494. 
 
 
(S)-1-(4-chlorophenyl)-1-methyl-3-(1-(pyridin-3-yl)ethyl)urea (17c) 
 
Following general procedure 1, N-methyl-N-(4-chlorophenyl) carbamoyl chloride (501 mg, 2.456 mmol, 1.2 
eq.), 3-pyridine 5a (er 98:2) (250 mg, 2.036 mmol, 1.0 eq.) and Et3N (570 μl, 4.072 mmol, 2.0 eq.) in 
acetonitrile (20.0 ml) gave after 20 h heating at reflux a crude product that was purified by flash column 
chromatography (SiO2, 99:1 to 97:3 CH2Cl2:MeOH) to yield 17c as a brown solid (248 mg, 42%). Rf 0.31 (95:5 
CH2Cl2:MeOH). 
1H NMR (400 MHz, CDCl3) δ = 8.51 (1H, d, J = 2.2, =CH), 8.48 (1H, dd, J = 4.8, 1.5, =CH), 7.55 
(1H, dt, J = 7.9, 1.8, =CH), 7.43 – 7.38 (2H, m, 2 x =CH), 7.25 – 7.17 (3H, m, 3 x =CH), 5.02 (1H, quint, J = 7.1, 
NHCHCH3), 4.49 (1H, d, J = 7.3, NHCHCH3), 3.22 (3H, s, NCH3), 1.38 (3H, d, J = 7.0, NHCHCH3). 
13C NMR (126 
MHz, CDCl3) δ = 156.1 (C=O), 148.6 (=CH), 147.9 (=CH), 141.9 (=C), 139.8 (=C), 133.9 (=CH), 133.4 (=C), 130.5 
(=CH), 128.8 (=CH), 123.5 (=CH), 48.4 (NHCHCH3), 37.4 (NCH3), 22.4 (NHCHCH3). Mp = 110-112 °C. []
  
 
 = 
+60 (c = 1.00; CH2Cl2). IR (film, cm
-1): νmax = 3319, 2975, 1647, 1516, 1492, 1341, 1091, 714. HRMS (ESI
+): 
m/z calcd for C15H17N3OCl [M+H]
+ 290.1055, found 290.1058. 
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(S)-1-(4-chlorophenyl)-1,3-dimethyl-3-(1-(pyridin-3-yl)ethyl)urea (7c) 
 
Following general procedure 2B, urea 17c (248 mg, 0.856 mmol), NaH (51 mg, 1.283 mmol), MeI (64 μL, 
1.027 mmol) in DMF (15.0 ml) gave after 3 h of stirring at room temperature a crude product that was 
purified by flash column chromatography (SiO2, 99:1 to 97:3 CH2Cl2:MeOH), to yield 7c as a yellow oil (215 
mg, 83%). Rf 0.22 (95:5 CH2Cl2:MeOH). 
1H NMR (500 MHz, CDCl3) δ = 8.54 (1H, d, J = 1.5 Hz, =CH), 8.50 (1H, 
d, J = 3.8 Hz, =CH), 7.61 (1H, d, J = 7.9 Hz, =CH), 7.31 – 7.22 (4H, m, 4 x =CH), 7.04 – 6.99 (2H, m, 2 x =CH), 
5.56 (1H, q, J = 7.1, NCHCH3), 3.21 (3H, s, CH3NC=CH), 2.24 (3H, s, CH3NCHCH3), 1.46 (3H, d, J = 7.1, 
NCHCH3). 
13C NMR (126 MHz, CDCl3) δ = 161.9 (C=O), 149.0 (=CH), 148.8 (=CH), 145.4 (=C), 136.5 (=C), 135.1 
(=CH), 130.3 (=C), 129.8 (=CH), 125.6 (=CH), 123.4 (=CH), 52.3 (NCHCH3), 40.2 (CH3NCHCH3), 31.2 
(CH3NC=CH), 15.6 (NCHCH3). Mp = 77-78 °C. []
  
 
 = -10 (c = 1.00; CH2Cl2). IR (film, cm
-1): νmax = 2974, 1642, 
1492, 1330, 1120, 834, 715. HRMS (ESI+): m/z calcd for C16H19N3OCl [M+H]
+ 304.1211, found 304.1214. 
 
(S)-1-methyl-1-(pyridin-2-yl)-3-(1-(pyridin-3-yl)ethyl)urea (17d) 
 
Following general procedure 1, N-methyl-N-(3-pyridyl) carbamoyl chloride (419 mg, 2.456 mmol, 1.2 eq.),  
3-pyridine 5a (er 98:2) (250 mg, 2.036 mmol, 1.0 eq.) and Et3N (570 μl, 4.072 mmol, 2.0 eq.) in acetonitrile 
(20.0 ml) gave after 2 h heating at reflux a crude product that was purified by flash column chromatography 
(SiO2, 99:1 to 97:3 CH2Cl2:MeOH) to yield 17d as a brown oil (203 mg, 39%). Rf 0.24 (95:5 CH2Cl2:MeOH). 
1H 
NMR (400 MHz, CDCl3) δ = 10.89 (1H, d, J = 6.7, NHCHCH3), 8.65 (1H, d, J = 2.2, =CH), 8.48 (1H, dd, J = 4.8, 
1.5,  =CH), 8.31 – 8.24 (1H, m, =CH), 7.75 – 7.65 (2H, m, 2 x =CH), 7.26 – 7.22 (1H, m, =CH), 7.01 – 6.95 (2H, 
m, 2 x =CH), 5.13 (1H, quint, J = 7.0, NCHCH3), 3.38 (3H, s, J = 8.4, NCH3), 1.57 (3H, d, J = 7.0, NHCHCH3). 
13C 
NMR (126 MHz, CDCl3) δ =  156.2 (C=O), 155.9 (=C), 148.4 (=CH), 148.2 (=CH), 140.4 (=C), 138.9 (=CH), 133.9 
(=CH), 123.5 (=CH), 117.1 (=CH), 111.6 (=CH), 48.6 (NHCHCH3), 32.9 (NCH3), 23.2 (NHCHCH3). []
  
 
 = +110 (c 
= 1.00; CH2Cl2). IR (film, cm
-1): νmax = 3172, 2972, 1666, 1529, 1435, 1317, 777. HRMS (ESI
+): m/z calcd for 
C14H17N4O [M+H]
+ 257.1397, found 257.1400. 
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(S)-1,3-dimethyl-3-(pyridin-2-yl)-1-(1-(pyridin-3-yl)ethyl)urea (7d) 
 
Following general procedure 2B, urea 17d (248 mg, 0.856 mmol), NaH (51 mg, 1.283 mmol), MeI (64 μL, 
1.027 mmol) in DMF (15.0 ml) gave after 3 h of stirring at room temperature a crude product that was 
purified by flash column chromatography (SiO2, 99:1 to 97:3 CH2Cl2:MeOH), to yield 7d as a yellow oil (215 
mg, 74%). Rf 0.28 (95:5 CH2Cl2:MeOH). 
1H NMR (500 MHz, CDCl3) δ = 8.64 (1H, s, =CH), 8.52 (1H, d, J = 4.2, 
=CH), 8.32 (1H, dd, J = 4.8, 1.3, =CH), 7.74 (1H, d, J = 7.9, =CH), 7.61 – 7.53 (1H, m, =CH), 7.33 – 7.22 (1H, m, 
=CH), 6.94 – 6.84 (2H, m, =CH), 5.69 (1H, q, J = 7.1, NCHCH3), 3.33 (3H, s, CH3NC=CH), 2.42 (3H, s, 
CH3NCHCH3), 1.59 (3H, d, J = 7.1, NCHCH3). 
13C NMR (126 MHz, CDCl3) δ 161.3 (C=O), 157.5 (=C), 149.1 
(=CH), 148.8 (=CH), 148.6 (=CH), 137.9 (=CH), 136.2 (=C), 135.3 (=CH), 123.5 (=CH), 117.8 (=CH), 114.3 (=CH), 
52.3 (NCHCH3), 36.5 (CH3NCHCH3), 30.7 (CH3NC=CH), 15.7 (NCHCH3). []
  
 
 = +10 (c = 1.00; CH2Cl2). IR (film, 
cm-1): νmax = 2978, 1651, 1589, 1477, 1428, 1332, 1104, 775. HRMS (ESI
+): m/z calcd for C15H18N4ONa 
[M+Na]+ 293.1373, found 293.1365. 
 
(R)-1-methyl-1-phenyl-3-(2-phenyl-1-(pyridin-3-yl)ethyl)urea (17e) 
 
Following general procedure 1, N-methyl-N-phenyl carbamoyl chloride (0.308 g, 1.816 mmol, 1.2 eq.),  
3-pyridine 5b (300 mg, 1.513 mmol, 1.0 eq.) and Et3N (422 μl, 3.026 mmol, 2.0 eq.) in acetonitrile (15.0 ml) 
gave, after 20 h heating at reflux, a crude product that was purified by flash column chromatography (SiO2, 
99:1 to 97:3 CH2Cl2:MeOH) to yield 17e as a brown oil (261 mg, 52%). Rf 0.18 (95:5 CH2Cl2:MeOH).
1H NMR 
(400 MHz, CDCl3) δ = 8.46 (1H, dd, J = 4.8, 1.6, =CH), 8.41 (1H, d, J = 2.2, =CH), 7.47 – 7.29 (4H, m, 4 x =CH), 
7.23 – 7.14 (4H, m, 4 x =CH), 7.09 – 7.03 (2H, m, 2 x =CH), 6.88 – 6.80 (2H, m, 2 x =CH), 5.12 (1H, dd, J = 
14.6, 6.5, NHCHCH2), 4.65 (1H, d, J = 6.8, NHCHCH2), 3.17 (3H, s, N-CH3), 3.00 (1H, dd, J = 13.8, 6.0, 
NHCHCHAHB), 2.80 (1H, dd, J = 13.8, 8.2, NHCHCHAHB); 
13C NMR (100 MHz, CDCl3) δ = 156.4 (C=O), 148.4 
(=CH), 148.1 (=CH), 143.0 (=C), 138.6 (=C), 136.6 (=C), 134.3 (=CH), 130.3 (=CH), 129.3 (=CH), 128.7 (=CH), 
127.7 (=CH), 127.5 (=CH), 126.9 (=CH), 123.3 (=CH), 53.8 (NHCHCH2), 43.0 (NHCHCH2), 37.1 (NCH3). []
  
 
 =  
-10 (c = 1.00; CH2Cl2). IR (film, cm
-1): νmax = 3337, 3028, 2926, 1656, 1495. HRMS (ESI
+): m/z calcd for 
C21H21N3ONa [M+Na]
+ 354.1577, found 354.1561. 
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(R)-1,3-dimethyl-3-phenyl-1-(2-phenyl-1-(pyridin-3-yl)ethyl)urea (7e) 
 
Following general procedure 2B, urea 17e (224 mg, 0.677 mmol), NaH (41 mg, 1.016 mmol), MeI (51 μL, 
0.813 mmol) in DMF (6.8 ml) gave after 2 h of stirring at room temperature a crude product that was 
purified by flash column chromatography (SiO2, 99:1 to 97:3 CH2Cl2:MeOH), to obtain 7e as an orange oil 
(211 mg, 90%). Rf 0.18 (95:5 CH2Cl2:MeOH). 
1H NMR (400 MHz, CDCl3) δ = 8.66 (1H, d, J = 2.2, =CH), 8.51 
(1H, dt, J = 18.8, 9.4, =CH), 7.80 (1H, dt, J = 7.9, 1.7, =CH), 7.44 – 7.23 (6H, m, 6 x =CH), 7.10 – 6.95 (3H, m, 3 
x =CH), 6.48 – 6.40 (2H, m, 2 x =CH), 6.02 (1H, dd, J = 11.4, 5.5, NCHCH2), 3.34 (1H, dd, J = 14.4, 5.5 Hz, 
NCHCHAHB), 3.12 (3H, s, =CH-NCH3), 3.09 (1H, dd, J = 14.4, 11.4, NCHCHAHB), 2.23 (3H, s, CH2CHNCH3).  
13C NMR (100 MHz, CDCl3) δ = 162.1 (C=O), 149.2 (=CH), 148.9 (=CH), 146.5 (=C), 137.9 (=C), 135.9 (2 peaks, 
=CH, =C), 129.6 (=CH), 129.1 (=CH), 129.0 (=CH), 126.9 (=CH), 124.5 (=CH), 124.3 (=CH), 123.5 (=CH), 57.1 
(NCHCH2), 40.5 (=CH-NCH3), 36.6 (NCHCH2), 31.6 (CH2CHNCH3). []
  
 
 = +95 (c = 1.00; CH2Cl2). IR (film, cm
-1): 
νmax = 3029, 2931, 1634, 1494, 1342, 1118. HRMS (ESI
+): m/z calcd for C22H24N3O [M+H]
+ 346.1914, found 
346.1900. 
 
(R)-1-(3-chlorophenyl)-1-methyl-3-(2-phenyl-1-(pyridin-3-yl)ethyl)urea (17f) 
 
Following general procedure 1, N-methyl-N-(3-chlorophenyl) carbamoyl chloride (0.371 g, 1.816 mmol, 1.2 
eq.), 3-pyridine 5b (300 mg, 1.513 mmol, 1.0 eq.) and Et3N (420 μL, 3.026 mmol, 2.0 eq.) in acetonitrile 
(11.0 ml) gave, after 2 h heating at reflux, a crude product that was purified by flash column 
chromatography (SiO2, 97:3 to 95:5 CH2Cl2:MeOH) to yield 17f as a brown oil (474 mg, 86%). Rf 0.23 (95:5 
CH2Cl2:MeOH). 
1H NMR (400 MHz, CDCl3) δ =
 8.41 (1H, dd, J = 4.8, 1.6, =CH), 8.37 (1H, d, J = 2.3, =CH), 7.41 – 
7.35 (1H, m, =CH), 7.26 – 7.22 (2H, m, 2 x =CH), 7.18 – 7.10 (4H, m, 4 x =CH), 7.05 (1H, dt, J = 2.0, 0.9, =CH), 
6.89 – 6.85 (1H, m, =CH), 6.85 – 6.78 (2H, m, 2 x =CH), 5.06 (1H, dt, J = 8.2, 6.4, NHCHCH2), 4.56 (1H, d, J = 
6.7, NHCHCH2), 3.09 (3H, s, NCH3), 2.99 (1H, dd, J = 13.9, 5.9, NHCHCHAHB), 2.76 (1H, dd, J = 13.9, 8.4, 
NHCHCHAHB). 
13C NMR (100 MHz, CDCl3) δ =
 155.9 (C=O), 148.6 (=CH), 148.1 (=CH), 144.3 (=C), 138.4 (=C), 
136.5 (=C), 135.6 (=C), 134.3 (=CH), 131.2 (=CH), 129.3 (=CH), 128.8 (=CH), 127.9 (=CH), 127.8 (=CH), 127.1 
(=CH), 125.6 (=CH), 123.4 (=CH), 53.9 (NHCHCH2), 42.9 (NHCHCH2), 37.2 (NCH3). []
  
 
 = -10 (c = 1.00; 
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CH2Cl2). IR (film, cm
-1): νmax = 3310, 3028, 1656, 1591, 1509, 1337. HRMS (ESI
+): m/z calcd for C21H21N3OCl 
[M+H]+ 366.1368, found 366.1354. 
 
(R)-1-(3-chlorophenyl)-1,3-dimethyl-3-(2-phenyl-1-(pyridin-3-yl)ethyl)urea (7f) 
 
Following general procedure 2B, urea 17f (282 mg, 0.772 mmol), NaH (51 mg, 1.278 mmol), MeI (64 μL, 
1.02 mmol) in DMF (8.5 ml) gave gave after 2 h of stirring at room temperature a crude product that was 
purified by flash column chromatography (SiO2, 99:1 to 97:3 CH2Cl2:MeOH),to obtain 7f as a yellow oil (282 
mg, 96%). Rf 0.18 (95:5 CH2Cl2:MeOH). 
1H NMR (400 MHz, CDCl3) δ = 8.61 (1H, d, J = 1.5, =CH), 8.47 (1H, d, J 
= 3.6 Hz, =CH), 7.75 – 7.69 (1H, m, =CH), 7.35 – 7.17 (6H, m, =CH), 6.93 – 6.75 (3H, m, =CH), 5.96 – 5.88 (2H, 
m, =CH and NCHCH2), 3.28 (1H, dd, J = 14.5, 5.7, NCHCHAHB), 3.12 – 3.04 (1H, m, NCHCHAHB), 3.02 (3H, s, 
=CH-NCH3), 2.23 (3H, s, CH2CHNCH3). 
13C NMR (100 MHz, CDCl3) δ = 161.6 (C=O), 149.2 (=CH), 149.1 (=CH), 
147.6 (s), 137.7 (=C), 135.9 (=CH), 135.5 (=C), 134.8 (=C), 130.6 (=CH), 129.0 (2 x =CH), 127.0 (=CH), 124.5 
(=CH), 123.8 (=CH), 123.6 (=CH), 121.8 (=CH), 57.4 (NCHCH2), 40.0 (=CH-NCH3), 36.5 (NCHCH2), 31.8 
(CH2CHNCH3). []
  
 
 = +110 (c = 1.00; CH2Cl2). IR (film, cm
-1): νmax = 3028, 2925, 1640, 1591, 1478, 1330, 
1099. HRMS (ESI+): m/z calcd for C22H23N3OCl [M+H]
+ 380.1524, found 380.1511.  
 
(R)-1-(3-methoxyphenyl)-1-methyl-3-(2-phenyl-1-(pyridin-3-yl)ethyl)urea (17g) 
 
Following general procedure 1, N-methyl-N-(3-methoxyphenyl) carbamoyl chloride (0.302 g, 1.513 mmol, 
1.2 eq.), 3-pyridine 5b (250 mg, 1.261 mmol, 1.0 eq.) and Et3N (350 μl, 2.522 mmol, 2.0 eq.) in acetonitrile 
(13.0 ml) gave, after 2 h heating at reflux, a crude product that was purified by flash column 
chromatography (SiO2, 99:1 to 97:3 CH2Cl2:MeOH) to yield 17g as a brown oil (313 mg, 69%). Rf 0.17 (95:5 
CH2Cl2:MeOH). 
1H NMR (400 MHz, CDCl3) δ = 8.46 (1H, dd, J = 4.8, 1.5, =CH), 8.41 (1H, d, J = 2.1, =CH), 7.42 
(1H, dt, J = 7.8, 1.8, =CH), 7.33 – 7.24 (2H, m, 2 x =CH), 7.22 – 7.13 (3H, m, 3 x =CH), 6.91 – 6.81 (3H, m, 3 x 
=CH), 6.67 – 6.60 (2H, m, 2 x =CH), 5.11 (1Hz, dd, J = 6.8, 6.6, NHCHCH2), 4.75 (1H, d, J = 6.8, NHCHCH2), 3.79 
(3H, s, OCH3), 3.16 (3H, s, N-CH3), 3.00 (1H, dd, J = 13.8, 6.1, NHCHCHAHB), 2.82 (1H, dd, J = 13.8, 8.1, 
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NHCHCHAHB). 
13C NMR (100 MHz, CDCl3) δ = 161.0 (C=O), 156.3 (=C-OCH3), 148.5 (=CH), 148.2 (=CH), 144.2 
(=C), 138.6 (=C), 136.6 (=C), 134.3 (=CH), 131.0 (=CH), 129.3 (=CH), 128.7 (=CH), 126.9 (=CH), 123.4 (=CH), 
119.5 (=CH), 113.5 (=CH), 113.0 (=CH), 55.5 (OCH3), 53.8 (NHCHCH2), 43.0 (NHCHCH2), 37.1 (NCH3). IR (film, 
cm-1): νmax = 3322, 3028, 2935, 1659, 1598, 1489. HRMS (ESI
+): m/z calcd for C22H24N3O2 [M+H]
+ 362.1863, 
found 362.1848. 
 
(R)-1-(3-methoxyphenyl)-1,3-dimethyl-3-(2-phenyl-1-(pyridin-3-yl)ethyl)urea (7g) 
 
Following general procedure 2B, urea 17g (236 mg, 0.653 mmol), NaH (39 mg, 0.979 mmol), MeI (49 μL, 
0.784 mmol) in DMF (7.0 ml) gave after 2 h of stirring at room temperature a crude product that was 
purified by flash column chromatography (SiO2, 99:1 to 97:3 CH2Cl2:MeOH), to obtain 7g as a yellow oil 
(86mg, 35%). Rf 0.27 (95:5 CH2Cl2:MeOH). 
1H NMR (500 MHz, CDCl3) δ = 8.63 (1H, br s, =CH), 8.50 (1H, d, J = 
4.1, =CH), 7.75 (1H, d, J = 7.9, =CH), 7.34 (2H, t, J = 7.4, 2 x =CH), 7.30 – 7.22 (3H, m, 3 x =CH), 6.91 (1H, t, J = 
8.1, =CH), 6.60 – 6.53 (1H, m, =CH), 6.45 (1H, t, J = 2.2, =CH), 5.94 (1H, dd, J = 10.3, 6.2, =CH), 5.86 (1H, d, J = 
7.9, =CH), 3.70 (3H, s, OCH3), 3.32 (1H, dd, J = 14.4, 6.2, NCHCHAHB), 3.17 – 3.12 (1H, m, NCHCHAHB), 3.10 
(3H, s, CH2CHNCH3), 2.32 (3H, s, =CH-NCH3). 
13C NMR (126 MHz, CDCl3) δ = 161.9 (C=O), 160.5 (=C), 149.3 
(=CH), 148.9 (=CH), 147.7 (=C), 137.8 (=C), 135.9 (=CH), 135.6 (=C), 130.3 (=CH), 129.0 (=CH), 128.9 (=CH), 
126.8 (=CH), 123.5 (=CH), 116.6 (=CH), 110.3 (=CH), 109.8 (=CH), 57.5 (NCHCH2), 55.3 (OCH3), 40.3 (=CH-
NCH3), 36.6 (NCHCH2), 31.6 (CH2CHNCH3). []
  
 
 = +65 (c = 1.00; CH2Cl2). IR (film, cm
-1): νmax = 2938, 1637, 
1594, 1487, 1328, 1111, 1042, 699. HRMS (ESI+): m/z calcd for C23H26N3O2 [M+H]
+ 376.2020, found 
376.2025. 
 
(R)-1-methyl-3-(2-phenyl-1-(pyridin-3-yl)ethyl)-1-(pyridin-2-yl)urea (17h) 
 
Following general procedure 1, N-methyl-N-(3-pyridyl)) carbamoyl chloride (310 mg, 1.816 mmol, 1.2 eq.), 
3-pyridine 5b (300 mg, 1.513 mmol, 1.0 eq.) and Et3N (420 μl, 3.026 mmol, 2.0 eq.) in acetonitrile (15.0 ml) 
gave after 2 h heating at reflux a crude product that was purified by flash column chromatography (SiO2, 
97:3 CH2Cl2:MeOH) to yield 17h as a brown oil (450 mg, 90%). Rf 0.15 (95:5 CH2Cl2:MeOH). 
1H NMR (400 
MHz, CDCl3) δ = 11.10 (1H, d, J = 7.0 Hz, NHCHCH2), 8.51 (1H, d, J = 2.2 Hz, =CH), 8.46 (1H, dd, J = 4.8, 1.6 Hz, 
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=CH), 8.19 (1H, ddd, J = 5.0, 2.0, 0.8 Hz, =CH), 7.70 (1H, ddd, J = 8.6, 7.4, 2.0 Hz, =CH), 7.48 (1H, dt, J = 7.9, 
1.8 Hz, =CH), 7.28 – 7.15 (4H, m, 4 x =CH), 7.08 – 7.03 (2H, m, 2 x =CH), 6.99 – 6.93 (2H, m, 2 x =CH), 5.32 
(1H, q, J = 6.8 Hz, NHCHCH2), 3.33 (3H, s, N-CH3), 3.18 – 3.13 (2H, m, NHCHCH2). 
13C NMR (101 MHz, CDCl3) 
δ = 156.0 (C=O and N=C-N), 148.6 (=CH), 148.4 (=CH), 145.7 (=CH), 138.9 (=CH), 138.5 (=C), 137.1 (=C), 134.5 
(=CH), 129.9 (=CH), 128.4 (=CH), 126.8 (=CH), 123.2 (=CH), 117.1 (=CH), 111.5 (=CH), 54.7 (NHCHCH2), 43.6 
(NHCHCH2), 32.7 (NCH3). []
  
 
 = -5 (c = 1.00; CH2Cl2). Mp = 85-86 °C. IR (film, cm
-1): νmax = 3028, 1665, 1521, 
1434, 1316. HRMS (ESI+): m/z calcd for C20H21N4O [M+H]
+ 333.1710, found 333.1705. 
 
(R)-1,3-dimethyl-1-(2-phenyl-1-(pyridin-3-yl)ethyl)-3-(pyridin-2-yl)urea (7h) 
 
Following general procedure 2B, urea 17h (330 mg, 0.993 mmol), NaH (60 mg, 1.490 mmol), MeI (74 μL, 
1.192 mmol) in DMF (10.0 ml) gave after 2.5 h of stirring at room temperature a crude product that was 
purified by flash column chromatography (SiO2, 97:3 CH2Cl2:MeOH), to obtain 7h as a yellow oil (286 mg, 
83%). Rf 0.21 (95:5 CH2Cl2:MeOH). 
1H NMR (400 MHz, CDCl3) δ = 8.75 (1H, d, J = 2.0, =CH), 8.56 (1H, dd, J = 
4.7, 1.3, =CH), 8.24 (1H, ddd, J = 5.0, 2.0, 0.8 Hz, =CH), 7.87 (1H, dt, J = 7.9, 1.7 Hz, =CH), 7.45 – 7.28 (6H, m, 
6 x =CH), 7.21 (1H, ddd, J = 8.3, 7.3, 2.0, =CH), 6.78 (1H, ddd, J = 7.3, 4.9, 0.9, =CH), 6.06 (1H, dd, J = 11.4, 
5.6, NCHCH2), 5.89 (1H, d, J = 8.3, =CH), 3.43 (1H, dd, J = 14.5, 5.6, NCHCHAHB), 3.23 (1H, dd, J = 14.5, 11.5, 
NCHCHAHB), 3.14 (3H, s, CH2CHNCH3), 2.45 (3H, s, =CH-NCH3). 
13C NMR (101 MHz, CDCl3) δ = 161.5 (C=O), 
157.1 (=C), 149.2 (2 x =CH), 148.4 (=CH), 137.9 (=CH), 137.7 (=C), 135.9 (=CH), 135.3 (=C), 129.1 (2 x =CH), 
123.6 (=CH), 117.5 (=CH), 114.8 (=CH), 57.2 (NCHCH2), 36.6 (NCHCH2), 36.1 (=CH-NCH3), 31.4 (CH2CHNCH3). 
[]  
 
 = +90 (c = 1.00; CH2Cl2). HRMS (ESI
+): m/z calcd for C21H23N4O [M+H]
+ 347.1866, found 347.1851. 
 
1-(3-Chlorophenyl)-1-methyl-3-[(1S)-1-phenylethyl]urea (18a) 
 
Following general procedure 1, N-methyl-N-(3-chlorophenyl) carbamoyl chloride (1.40 g), 2-pyridine 6a 
(835 mg, 6.87 mmol), synthesized from 4, Et3N (1.05 ml) and DMAP (cat) in dichloroethane (17.20 ml) gave, 
after 20 h heating at reflux, a crude product that was purified by flash column chromatography (SiO2, 99:1 
to 90:10 DCM:MeOH) to yield the title compound as an oil (1.28 g, 64%). 1H NMR (400 MHz, CDCl3) δ = 
20 
 
8.50-8.38 (1H, m, =CH), 7.64 (1H, td, J = 7.7 and 1.4, =CH), 7.35 (1H, t, J = 7.9, =CH), 7.30-7.21 (3H, m, 3 x 
=CH), 7.20-7.09 (2H, m, 2 x =CH), 5.97-5.79 (1H, brd, CHNH), 5.05 (1H, q, J = 6.9, NHCHCH3), 3.27 (3H, s, 
NCH3), 1.41 (3H, d, J = 6.8, CHCH3). 
13C NMR (100 MHz, CDCl3) δ = 161.8 (C=O), 156.3 (=C), 148.9 (=CH), 
144.9 (=C), 137.0 (=CH), 135.2 (=C), 130.8 (=CH), 127.3 (=CH), 127.1 (=CH), 125.2 (=CH), 122.3 (=CH), 121.5 
(=CH), 51.2 (NCH), 37.2 (NCH3), 23.1 (CH3). []
  
 
 = -137 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 3320, 2971, 
2928, 1642. HRMS (ESI+): m/z calcd for C15H16ClN3ONa [M+Na]
+ 312.0880, found 312.0871. 
 
1-(3-Chlorophenyl)-1,3-dimethyl-3-[(1S)-1-phenylethyl]urea (8a) 
 
Following general procedure 2A, urea 18a (689 mg, 2.38 mmol), MeI (0.18 ml), NaH (124 mg) in THF (5.95 
ml) gave, after purification by flash column chromatography (SiO2, 80:20 to 0:100 Pet.Ether:EtOAc), 8a as 
an oil (720 mg, 99%).1H NMR (400 MHz, CDCl3) δ = 8.61-8.52 (1H, m, =CH), 7.65 (1H, td, J = 7.7 and 1.7, 
=CH), 7.32 (1H, d, J = 7.9, =CH), 7.21 (1H, t, J = 8.1, =CH), 7.18-7.10 (2H, m, 2 x =CH), 7.06-7.01 (1H, m, =CH), 
7.00-6.95 (1H, m, =CH), 5.25 (1H, q, J = 7.1, NCHCH3), 3.23 (3H, s, NCH3), 2.38 (3H, s, NCH3), 1.52 (3H, d, J = 
7.1, CHCH3). 
13C NMR (100 MHz, CDCl3) δ = 161.6 (C=O), 160.2 (=C), 149.0 (=CH), 147.9 (=C), 136.7 (=CH), 
134.9 (=C), 130.4 (=CH), 124.3 (=CH), 123.8 (=CH), 122.5 (=CH), 122.3 (=CH), 121.6 (=CH), 56.0 (NCH), 39.7 
(NCH3), 31.6 (NCH3), 15.5 (CH3). []
  
 
 = -237 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 2992, 2945, 1639. HRMS 
(ESI+): m/z calcd for C16H18ClN3ONa [M+H]
+ 326.1036, found 326.1048. 
 
1,3-dimethyl-1-phenyl-3-[(1S)-1-(pyridin-2-yl)propyl]urea (18b) 
 
Following general procedure 1, N-methyl-N-phenyl carbamoyl chloride (477 mg), 2-pyridine 6b (383 mg, 
2.81 mmol), synthesized from 4, and Et3N (431 μl) in acetonitrile (7.00 ml) gave, after 20 h heating at reflux, 
a crude product that was purified by flash column chromatography (SiO2, 99:1 to 90:10 DCM:MeOH) to 
yield 18b as an oil (280 mg, 37%). 1H NMR (400 MHz, CDCl3) δ = 8.45-8.37 (1H, m, =CH), 7.60 (1H, td, J = 7.6 
and 1.8, =CH), 7.47-7.38 (2H, m, 2 x =CH), 7.34-7.23 (3H, m, 3 x =CH), 7.22-7.18 (1H, m, =CH), 7.11 (1H, ddd, 
J = 7.5, 4.9 and 1.1, =CH), 5.50 (1H, d, J = 8.0, CHNH), 4.87 (1H, dt, J = 7.8 and 6.9, NHCHCH2), 3.26 (3H, s, 
NCH3), 1.85-1.63 (2H, m, CHCH2CH3), 0.78 (3H, t, J = 7.4, CH2CH3). 
13C NMR (100 MHz, CDCl3) δ = 161.3 
(C=O), 157.0 (=C), 149.2 (=CH), 143.5 (=C), 136.5 (=CH), 130.0 (=CH), 127.3 (=CH), 127.2 (=CH), 122.2 (=CH), 
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122.1 (=CH), 56.8 (NCH), 37.3 (NCH3), 29.5 (CH2), 10.3 (CH3). []
  
 
 = -151 (c = 1.00; CHCl3). IR (film, cm
-1): 
νmax = 3421, 2965, 2931, 1658, 750. HRMS (ESI
+): m/z calcd for C16H20N3O [M+H]
+ 270.1601, found 270.1607. 
 
1,3-dimethyl-1-phenyl-3-[(1S)-1-(pyridin-2-yl)propyl]urea (8b) 
 
Following General procedure 2A, urea 18b (230 mg, 0.85 mmol), MeI (0.06 ml), NaH (45 mg) in THF (2.13 
ml) gave, after purification by flash column chromatography (SiO2, 80:20 to 0:100 Pet.Ether:EtOAc), 8b as 
an oil (230 mg, 95%).1H NMR (400 MHz, CDCl3) δ = 8.57-8.47 (1H, m, =CH), 7.62 (1H, td, J = 10.7 and 1.8, 
=CH), 7.34 (1H, d, J =, =CH), 7.31-7.25 (2H, m, 2 x =CH), 7.14 (1H, ddd, J = 7.5, 4.9 and 1.1, =CH), 7.11-7.05 
(3H, m, 3 x =CH), 5.25 (1H, dd, J = 8.9 and 6.7, NCHCH2), 3.21 (3H, s, NCH3), 2.43 (3H, s, NCH3), 2.13 (1H, 
dquint, J = 14.4 and 7.3, CHCHAHBCH3), 1.83 (1H, ddq, J = 14.0, 8.9 and 7.5, CHCHAHBCH3), 0.91 (3H, t, J = 7.4, 
CH2CH3). 
13C NMR (100 MHz, CDCl3) δ = 162.7 (C=O), 160.0 (=C), 148.8 (=CH), 147.1 (=C), 136.5 (=CH), 129.5 
(=CH), 124.7 (=CH), 124.6 (=CH), 123.6 (=CH), 122.2 (=CH), 61.9 (NCH), 40.4 (NCH3), 31.5 (NCH3), 23.3 (CH2), 
11.5 (CH3). []
  
 
 = -88 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 2968, 2931, 1641. HRMS (ESI
+): m/z calcd for 
C17H22N3O [M+H]
+ 284.1757, found 284.1760. 
 
1,3-dimethyl-1-phenyl-3-[(1S)-1-(pyridin-2-yl)but-3-en-1-yl]urea (18c) 
 
Following general procedure 1, N-methyl-N-phenyl carbamoyl chloride (230 mg), 2-pyridine 6c (200 mg, 
1.35 mmol), synthesized from 4, and Et3N (207 μl) in acetonitrile (3.40 ml) gave, after 20 h heating at reflux, 
a crude product that was purified by flash column chromatography (SiO2, 99:1 to 90:10 DCM:MeOH) to 
yield 18c as an oil (270 mg, 71%). 1H NMR (400 MHz, CDCl3) δ = 8.48-8.37 (1H, m, =CH), 7.60 (1H, td, J = 7.7 
and 1.8, =CH), 7.47-7.37 (2H, m, 2 x =CH), 7.35-7.23 (3H, m, 3 x =CH), 7.20 (1H, d, J = 7.8, =CH), 7.11 (1H, 
ddd, J = 7.5, 4.8 and 1.0, =CH), 5.61 (1H, ddt, J = 17.1, 10.4 and 7.2, CH2CH=CH2), 5.43 (1H, d, J = 7.7, CHNH), 
5.01 (1H, dt, J = 7.1 and 6.8, NHCHCH2), 4.97-4.83 (2H, m, =CH2), 3.26 (3H, s, NCH3), 2.61-2.39 (2H, m, 
CHCH2CH=). 
13C NMR (100 MHz, CDCl3) δ = 160.9 (C=O), 156.8 (=C), 149.2 (=CH), 143.5 (=C), 136.5 (=CH), 
134.4 (=CH), 130.0 (=CH), 127.4 (=CH), 127.3 (=CH), 122.1 (=CH), 121.9 (=CH), 117.9 (=CH2), 55.1 (NCH), 40.7 
(CH2), 37.3 (NCH3). []
  
 
 = +40 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 3080, 2946, 1656, 1493. HRMS (ESI
+): 
m/z calcd for C17H20N3O [M+H]
+ 282.1601, found 282.1602. 
22 
 
1,3-dimethyl-1-phenyl-3-[(1S)-1-(pyridin-2-yl)but-3-en-1-yl]urea (8c) 
 
Following General procedure 2A, urea 18c (260 mg, 0.92 mmol), MeI (0.07 mL), NaH (48 mg) in THF (2.30 
mL) gave, after purification by flash column chromatography (SiO2, 80:20 to 0:100 Pet.Ether:EtOAc), 8c as 
an oil (230 mg, 95%). 1H NMR (400 MHz, CDCl3) δ = 8.58-8.45 (1H, m, =CH), 7.62 (1H, td, J = 7.8 and 1.8, 
=CH), 7.37 (1H, d, J = 7.9, =CH), 7.30-7.21 (2H, m, 2 x =CH), 7.13 (1H, ddd, J = 7.5, 4.9 and 0.8, =CH), 7.12-
7.03 (3H, m, 3 x =CH), 5.82 (1H, dddd, J = 17.2, 10.2, 8.2 and 5.6, CH2=CHCH2), 5.53 (1H, dd, J = 9.7 and 5.9, 
NCHCH2), 5.17-4.99 (2H, m, =CH2), 3.22 (3H, s, NCH3), 2.95-2.82 (1H, m, CHCHAHBCH=), 2.70-2.54 (1H, m, 
CHCHAHBCH=), 2.41 (3H, s, NCH3). 
13C NMR (100 MHz, CDCl3) δ = 162.5 (C=O), 159.6 (=C), 148.8 (=CH), 146.9 
(=C), 136.6 (=CH), 135.8 (=CH), 129.4 (=CH), 124.7 (2 x =CH), 123.6 (=CH), 122.4 (=CH), 117.3 (=CH2), 60.0 
(NCH), 40.4 (NCH3), 34.6 (CH2), 31.8 (NCH3). []
  
 
 = -96 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 3064, 3005, 
2925, 1640. HRMS (ESI+): m/z calcd for C18H22N3O [M+H]
+ 296.1757, found 296.1761. 
 
(S)-1-(4-methoxybenzyl)-3-methyl-3-phenyl-1-(1-(pyridin-3-yl)ethyl)urea (9), er 73:27 
 
To a solution of 5c (1.299 g, 5.36 mmol) in CH2Cl2 (54 mL) at room temperature was added phenyl 
isocyanate (0.58 mL, 5.36 mmol) and the reaction mixture was stirred at room temperature for 3 h. The 
reaction mixture was evaporated in vacuo. The residue was dissolved in anhydrous DMF (54 mL), and the 
solution was cooled down to 0 °C. To the solution was added in portions NaH (60% suspension in oil, 0.43 g, 
10.72 mmol). The reaction mixture was stirred at 0 °C for 15 min, then MeI (0.500 mL, 8.04 mmol) was 
added dropwise. The reaction mixture was allowed to warm up to room temperature and was stirred 
overnight. Then it was quenched at room temperature with water and evaporated in vacuo. The residue 
was dissolved in ethyl acetate and extracted from water three times. The combined organic layer was 
washed with brine, dried over MgSO4 and evaporated in vacuo. The crude product was purified by flash 
column chromatography (50:50 Petrol-EtOAc, then 0:100) to give 9 as a brown oil (1.48 g, 74%, er 73:27). 
Rf 0.37 (100% EtOAc). 
1H NMR (400 MHz, CDCl3) δ = 8.48 (1H, dd, J = 4.7, 1.6, =CH), 8.41 (1H, d, J = 2.3, 
=CH), 7.52 (1H, dt, J = 8.0, 1.9, =CH), 7.35 – 7.29 (2H, m, 2 x =CH), 7.25 – 7.13 (2H, m, 2 x =CH), 6.99 – 6.93 
(2H, m, 2 x =CH), 6.92 – 6.86 (2H, m, 2 x =CH), 6.80 – 6.74 (2H, m, 2 x =CH), 5.26 (1H, q, J = 7.0, CH-CH3), 
3.87 (1H, d, J = 15.5, NHCHAHB), 3.77 (3H, s, OCH3), 3.71 (1H, d, J = 15.5, NHCHAHB), 3.10 (3H, s, NCH3), 1.37 
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(3H, d, J = 7.0, CH-CH3).
 13C NMR (101 MHz, CDCl3) δ = 162.5 (C=O), 158.6 (=C), 149.2 (=CH), 148.7 (=CH), 
146.4 (=C), 136.9 (=C), 135.2 (=CH), 130.8 (=C), 129.6 (=CH), 128.7 (=CH), 125.5 (=CH), 125.0 (=CH), 123.3 
(=CH), 113.6 (=CH), 55.3 (OCH3), 54.4 (CH-CH3), 47.3 (NHCH2), 39.9 (NCH3), 16.5 (CH-CH3). IR (film, cm
-1): νmax 
= 2996, 2928, 2835, 1644, 1495, 1243. []  
 
 = +11.9 (c = 1.00; CH2Cl2); HRMS (ESI
+): m/z calcd for 
C23H26N3O2 [M+H]
+ 376.2020, found 376.2007. 
 
1-[(4-[Methoxyphenyl)methyl]-3,3-dimethyl-1-[(1S)-1-(pyridin-2-yl)ethyl]urea (10a) 
 
Following General procedure 1, N-methyl-N-phenyl carbamoyl chloride (77 mg), 2-pyridine 6d (100 mg, 
0.41 mmol) and Et3N (63 μl) in acetonitrile (1.03 ml) gave, after 20 h heating at reflux, a crude product that 
was purified by flash column chromatography (SiO2, 80:20 to 20:80 Pet.Ether:EtOAc) to yield 10a as an oil 
(155 mg, quant.). 1H NMR (400 MHz, CDCl3) δ = 8.55-8.44 (1H, m, =CH), 7.66-7.53 (1H, m, =CH), 7.33-7.06 
(5H, m, 5 x =CH), 6.99-6.82 (4H, m, 4 x =CH), 6.81-6.66 (2H, m, 2 x =CH), 5.39-5.19 (1H, m, NCHCH3), 4.06 
(1H, d, J = 15.7, NCHAHB), 3.85-3.64 (1H, superimposed d, NCHAHB), 3.78 (3H, s, OCH3), 3.08 (3H, s, NCH3), 
1.39 (3H, d, J = 7.0, CHCH3). 
13C NMR (100 MHz, CDCl3) δ = 162.5 (C=O), 160.6 (=C), 158.4 (=C), 149.0 (=CH), 
146.4 (=C), 136.5 (=CH), 131.5 (=C), 129.4 (=CH), 128.7 (=CH), 125.0 (=CH), 124.6 (=CH), 123.0 (=CH), 122.4 
(=CH), 113.5 (=CH), 57.9 (NCH), 55.4 (OCH3), 47.0 (CH2), 39.6 (NCH3), 16.2 (CH3). []
  
 
 = +90 (c = 1.00; CHCl3). 
IR (film, cm-1): νmax = 2941, 2928, 1644, 1247. HRMS (ESI
+): m/z calcd for C23H26N3O2 [M+H]
+ 376.2025, found 
376.2026. 
 
3-[(4-[Methoxyphenyl)methyl]-1-methyl-1-(4-methylphenyl)-3-[(1S)-1-(pyridin-2-yl)ethyl]urea (10b) 
 
Following General procedure 1, N-methyl-N-(4-methylphenyl) carbamoyl chloride (39 mg), 2-pyridine 6d 
(50 mg, 0.21 mmol) and Et3N (32 μl) in acetonitrile (0.52 ml) gave, after 20 h heating at reflux, a crude 
product that was purified by flash column chromatography (SiO2, 80:20 to 20:80 Pet.Ether:EtOAc) to yield 
10b as an oil (52 mg, 64%). 1H NMR (400 MHz, CDCl3) δ = 8.57-8.44 (1H, m, =CH), 7.66-7.54 (1H, m, =CH), 
7.24-7.05 (4H, m, 4 x =CH), 6.96-6.81 (4H, m, 4 x =CH), 6.80-6.70 (2H, m, 2 x =CH), 5.34 (1H, q, J = 7.0, 
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NCHCH3), 4.07 (1H, d, J = 15.5, NCHAHB), 3.77 (1H, d, J = 15.4, NCHAHB), 3.77 (3H, s, OCH3), 3.06 (3H, s, 
NCH3), 2.32 (3H, s, CH3), 1.60 (3H, d, J = 7.0, CHCH3). 
13C NMR (100 MHz, CDCl3) δ = 162.6 (C=O), 160.8 (=C), 
158.4 (=C), 149.0 (=CH), 143.9 (=C), 136.4 (=CH), 134.8 (=C), 131.6 (=C), 130.0 (=CH), 128.7 (=CH), 124.7 
(=CH), 123.0 (=CH), 122.3 (=CH), 113.5 (=CH), 57.9 (NCH), 55.3 (OCH3), 47.0 (CH2), 39.9 (NCH3), 21.0 (CH3), 
16.2 (CH3). []
  
 
 = +20 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 2976, 1646, 1245, 1038. HRMS (ESI
+): m/z 
calcd for C24H28N3O2 [M+H]
+ 390.2176, found 390.2181. 
 
1-(3-Methoxyphenyl)-3-[(4-[methoxyphenyl)methyl]-1-methyl-3-[(1S)-1-(pyridin-2-yl)ethyl]urea (10c) 
 
Following General procedure 1, N-methyl-N-(3-methoxyphenyl) carbamoyl chloride (82 mg), 2-pyridine 6d 
(100 mg, 0.41 mmol) and Et3N (63 μl) in acetonitrile (1.03 ml) gave, after 20 h heating at reflux, a crude 
product that was purified by flash column chromatography (SiO2, 80:20 to 20:80 Pet.Ether:EtOAc) to yield 
10c as an oil (64 mg, 38%). 1H NMR (400 MHz, CDCl3) δ = 8.56-8.45 (1H, m, =CH), 7.60 (1H, td, J = 7.7 and 
1.8, =CH), 7.23-7.10 (3H, m, 3 x =CH), 6.97-6.89 (2H, m, 2 x =CH) , 6.78-6.71 (2H, m, 2 x =CH), 6.66 (1H, dd, J 
= 8.3 and 1.9, =CH), 6.61-6.54 (1H, m, =CH), 6.53-6.47 (1H, m, =CH), 5.35 (1H, q, J = 7.0, NCHCH3), 4.14 (1H, 
d, J = 15.5, NCHAHB), 3.84 (1H, d, J = 15.5, NCHAHB), 3.75 (3H, s, OCH3), 3.69 (3H, s, OCH3), 3.08 (3H, s, NCH3), 
1.43 (3H, d, J = 7.0, CHCH3). 
13C NMR (100 MHz, CDCl3) δ = 162.3 (C=O), 160.6 (=C), 160.4 (=C), 158.4 (=C), 
149.0 (=CH), 147.6 (=C), 136.5 (=CH), 131.6 (=C), 130.0 (=CH), 128.7 (=CH), 122.9 (=CH), 122.3 (=CH), 116.6 
(=CH), 113.5 (=CH), 110.7 (=CH), 109.8 (=CH), 57.9 (NCH), 55.3 (2 x OCH3), 47.0 (CH2), 39.5 (NCH3), 16.4 
(CH3). []
  
 
 = -34 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 2973, 2918, 1652, 1250, 1034. HRMS (ESI
+): m/z 
calcd for C24H28N3O3 [M+ H]
+ 406.2125, found 406.2130. 
 
1-(4-Chlorophenyl)-3-[(4-[methoxyphenyl)methyl]-1-methyl-3-[(1S)-1-(pyridin-2-yl)ethyl]urea (10d) 
 
Following general procedure 1, N-methyl-N-(4-chlorophenyl) carbamoyl chloride (43 mg), 2-pyridine 6d (50 
mg, 0.21 mmol) and Et3N (32 μl) in acetonitrile (0.52 ml) gave, after 20 h heating at reflux, a crude product 
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that was purified by flash column chromatography (SiO2, 80:20 to 20:80 Pet.Ether:EtOAc) to yield 10d as an 
oil (48 mg, 56%). 1H NMR (400 MHz, CDCl3) δ = 8.89-8.48 (1H, m, =CH), 7.64 (1H, td, J = 7.6 and 1.8, =CH), 
7.29-7.20 (3H, m, 3 x =CH), 7.18-7.10 (1H, m, =CH), 6.95-6.82 (4H, m, 4 x =CH), 6.79-6.69 (2H, m, 2 x =CH), 
5.35 (1H, q, J = 6.9, NCHCH3), 4.05 (1H, d, J = 15.7, NCHAHB), 3.80 (1H, d, J = 15.7, NCHAHB), 3.77 (3H, s, 
OCH3), 3.02 (3H, s, NCH3), 1.45 (3H, d, J = 7.0, CHCH3). 
13C NMR (100 MHz, CDCl3) δ = 162.1 (C=O), 160.4 
(=C), 158.5 (=C), 149.2 (=CH), 144.8 (=C), 136.6 (=CH), 131.3 (=C), 129.9 (=C), 129.4 (=CH), 128.5 (=CH), 125.2 
(=CH), 122.7 (=CH), 122.5 (=CH), 113.6 (=CH), 57.9 (NCH), 55.4 (OCH3), 47.2 (CH2), 39.2 (NCH3), 16.5 (CH3). 
[]  
 
 = +16 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 2978, 1648, 1245, 1040. HRMS (ESI
+): m/z calcd for 
C23H24ClN3O2Na [M+Na]
+ 432.1449, found 432.1448. 
 
1-(3-Chlorophenyl)-3-[(4-[methoxyphenyl)methyl]-1-methyl-3-[(1S)-1-(pyridin-2-yl)ethyl]urea (10e) 
 
Following General procedure 1, N-methyl-N-(3-chlorophenyl) carbamoyl chloride (84 mg), 2-pyridine 6d 
(100 mg, 0.41 mmol), Et3N (63 μl) and DMAP (cat.) in dichloroethane (1.03 ml) gave, after 20 h heating at 
reflux, a crude product that was purified by flash column chromatography (SiO2, 80:20 to 20:80 
Pet.Ether:EtOAc) to yield 10e as an oil (78 mg, 46%). 1H NMR (400 MHz, CDCl3) δ = 8.61-8.52 (1H, m, =CH), 
7.65 (1H, td, J = 7.7 and 1.8, =CH), 7.28-7.14 (3H, m, 3 x =CH), 7.06 (1H, ddd, J = 8.0, 1.9 and 0.9, =CH), 7.00-
6.96 (1H, m, =CH), 6.92-6.86 (2H, m, 2 x =CH), 6.82 (1H, ddd, J = 8.1, 2.2 and 0.9, =CH), 6.80-6.73 (2H, m, 2 x 
=CH), 5.36 (1H, q, J = 7.0, NCHCH3), 4.03 (1H, d, J = 15.6, NCHAHB), 3.81 (1H, d, J = 15.7, NCHAHB), 3.78 (3H, s, 
OCH3), 3.02 (3H, s, NCH3), 1.48 (3H, d, J = 7.0, CHCH3). 
13C NMR (100 MHz, CDCl3) δ = 161.8 (C=O), 160.3 
(=C), 158.5 (=C), 149.3 (=CH), 147.3 (=C), 136.7 (=CH), 134.7 (=C), 131.1 (=C), 130.2 (=CH), 128.5 (=CH), 124.4 
(=CH), 123.9 (=CH), 122.7 (=CH), 122.5 (=CH), 121.5 (=CH), 113.6 (=CH), 57.8 (NCH), 55.4 (OCH3), 47.3 (CH2), 
38.9 (NCH3), 16.4 (CH3). []
  
 
 = +36.6 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 2985, 1642, 1239, 1043. HRMS 
(ESI+): m/z calcd for C23H25ClN3O2 [M+H]
+ 410.1635, found 410.1638. 
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1-(2-Chlorophenyl)-3-[(4-[methoxyphenyl)methyl]-1-methyl-3-[(1S)-1-(pyridin-2-yl)ethyl]urea (10f) 
 
Following General procedure 1, N-methyl-N-(2-chlorophenyl) carbamoyl chloride (43 mg), 2-pyridine 6d (50 
mg, 0.21 mmol), Et3N (32 μl) and DMAP (cat.) in dichloroethane (0.52 ml) gave, after 20 h heating at reflux, 
a crude product that was purified by flash column chromatography (SiO2, 80:20 to 20:80 Pet.Ether:EtOAc) 
to yield 10f as an oil (83 mg, 96%). 1H NMR (400 MHz, CDCl3) δ = 8.53-8.42 (1H, m, =CH), 7.57 (1H, td, J = 7.7 
and 1.8, =CH), 7.48-7.38 (1H, m, =CH), 7.22-7.15 (2H, m, 2 x =CH), 7.14-7.07 (2H, m, 2 x =CH), 7.05-6.97 (2H, 
m, 2 x =CH), 6.93-6.85 (1H, m, =CH), 6.82-6.69 (2H, m, 2 x =CH), 4.95 (1H, q, J = 7.0, NCHCH3), 4.12 (1H, d, J 
= 15.0, NCHAHB), 3.85 (1H, d, J = 15.0, NCHAHB), 3.77 (3H, s, OCH3), 3.08 (3H, s, NCH3), 1.22 (3H, d, J = 7.0, 
CHCH3). 
13C NMR (100 MHz, CDCl3) δ = 162.9 (C=O), 160.4 (=C), 158.4 (=C), 148.8 (=CH), 143.7 (=C), 136.5 
(=CH), 131.8 (=C), 131.1 (=C), 130.8 (=CH), 129.4 (=CH), 129.3 (=CH), 128.0 (=CH), 127.9 (=CH), 122.9 (=CH), 
122.3 (=CH), 113.4 (=CH), 58.3 (NCH), 55.3 (OCH3), 47.1 (CH2), 38.4 (NCH3), 15.9 (CH3). []
  
 
 = -16 (c = 1.00; 
CHCl3). IR (film, cm
-1): νmax = 2993, 1640, 1235, 1039. HRMS (ESI
+): m/z calcd for C23H24ClN3O2Na [M+Na]
+ 
432.1449, found 432.1443. 
 
1-(4-Cyanophenyl)-3-[(4-[methoxyphenyl)methyl]-1-methyl-3-[(1S)-1-(pyridin-2-yl)ethyl]urea (10g) 
 
Following general procedure 1, N-methyl-N-(4-cyanophenyl) carbamoyl chloride (41 mg), 2-pyridine 6d (50 
mg, 0.21 mmol) and Et3N (32 μl) in acetonitrile (0.52 ml) gave, after 20 h heating at reflux, a crude product 
that was purified by flash column chromatography (SiO2, 80:20 to 20:80 Pet.Ether:EtOAc) to yield 10g as an 
oil (84 mg, quant. yield). 1H NMR (400 MHz, CDCl3) δ = 8.60-8.50 (1H, m, =CH), 7.68 (1H, td, J = 7.7 and 1.8, 
=CH), 7.55-7.45 (2H, m, 2 x =CH), 7.36-7.29 (1H, m, =CH), 7.21 (1H, ddd, J = 7.5, 4.8 and 1.0, =CH), 7.01-6.91 
(2H, m, 2 x =CH), 6.85-6.68 (4H, m, 4 x =CH), 5.46 (1H, q, J = 7.1, NCHCH3), 4.10 (1H, d, J = 15.8, NCHAHB), 
3.91 (1H, d, J = 15.8, NCHAHB), 3.76 (3H, s, OCH3), 2.95 (3H, s, NCH3), 1.60 (3H, d, J = 7.1, CHCH3). 
13C NMR 
(100 MHz, CDCl3) δ = 160.9 (C=O), 159.8 (=C), 158.8 (=C), 149.4 (=CH), 149.2 (=C), 136.8 (=CH), 133.2 (=CH), 
130.7 (=C), 128.1 (=CH), 122.7 (=CH), 122.5 (=CH), 120.1 (=CH), 119.2 (=C), 113.8 (=CH), 105.1 (CN), 57.7 
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(NCH), 55.4 (OCH3), 47.7 (CH2), 37.2 (NCH3), 16.8 (CH3). []
  
 
 = +12 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 
2935, 2221, 1657, 1245, 1034. HRMS (ESI+): m/z calcd for C24H24N4O2Na [M+Na]
+ 423.1791, found 423.1791. 
 
1-[(4-[Methoxyphenyl)methyl]-3-methyl-3-phenyl-1-[(1S)-1-(pyridin-2-yl)but-3-en-1-yl]urea (10h) 
 
Following general procedure 1, N-methyl-N-phenyl carbamoyl chloride (58 mg), 2-pyridine 6e (90 mg, 0.34 
mmol) and Et3N (52 μl) in acetonitrile (0.84 ml) gave, after 20 h heating at reflux, a crude product that was 
purified by flash column chromatography (SiO2, 80:20 to 20:80 Pet.Ether:EtOAc) to yield 10h as an oil (80 
mg, 59%). 1H NMR (400 MHz, CDCl3) δ = 8.50-8.41 (1H, m, =CH), 7.57 (1H, td, J = 7.7 and 1.8, =CH), 7.32-
7.22 (2H, m, 2 x =CH), 7.16-7.02 (3H, m, 3 x =CH), 6.95-6.88 (2H, m, =CH), 6.68 (4H, s, 4 x =CH), 5.67 (1H, 
dddd, J = 17.1, 10.0, 7.6 and 6.4, CH2=CHCH2), 5.30 (1H, t, J = 7.6, CHCH2), 5.09-4.90 (2H, m, =CH2), 4.23 (1H, 
d, J = 15.5, NCHAHB), 3.94 (1H, d, J = 15.5, NCHAHB), 3.75 (3H, s, OCH3), 3.04 (3H, s, NCH3), 2.94-2.79 (1H, m, 
CHACHBCH=), 2.68-2.52 (1H, m, CHACHBCH=). 
13C NMR (100 MHz, CDCl3) δ = 162.4 (C=O), 158.9 (=C), 158.3 
(=C) 149.0 (=CH), 143.4 (=C), 136.5 (=CH), 135.3 (=CH), 131.5 (=C), 129.4 (=CH), 128.5 (=CH), 124.9 (=CH), 
124.7 (=CH), 124.5 (=CH), 122.6 (=CH), 117.5 (=CH2), 113.4 (=CH), 61.9 (NCH), 55.3 (OCH3), 46.6 (CH2), 39.6 
(NCH3), 35.5 (CH2). []
  
 
 = -40 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 3064, 2930, 1642, 1244, 1036. HRMS 
(ESI+): m/z calcd for C25H28N3O2 [M+H]
+ 402.2176, found 402.2178. 
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- LDA-mediated rearrangement of ureas and their hydrolysis 
 
(R)-1,3-dimethyl-1-(1-phenyl-1-(pyridin-3-yl)ethyl)urea (11a)6 
 
Following General procedure 3, urea 7a (72 mg, 0.266 mmol), freshly prepared LDA (0.75 M in THF, 0.89 ml, 
0.666 mmol) and THF (2.7 ml) gave after purification by flash column chromatography (SiO2, 99:1 to 97:3 
CH2Cl2:MeOH), 11a as a yellow solid (47 mg, 65%). Rf 0.14 (95:5 CH2Cl2:MeOH); 
1H NMR (400 MHz, CDCl3) δ 
= 8.52 (1H, br s, =CH), 8.42 (1H, br s, =CH), 7.56 – 7.48 (m, 1H, =CH), 7.32 – 7.14 (6H, m, 6 x =CH), 4.13 (1H, 
br s, NHCH3), 2.83 (3H, s, CH3CNCH3), 2.55 (3H, d, J = 4.6 Hz, NHCH3), 2.08 (3H, s, CH3CNCH3). 
13C NMR (126 
MHz, CDCl3) δ = 159.7 (C=O), 148.6 (=CH), 147.9 (=CH), 144.7, 141.3, 134.6 (=CH), 128.9 (=CH), 127.6 (=CH), 
127.1 (=CH), 123.2 (=CH), 66.2 (CH3CNCH3), 34.6 (CH3CNCH3), 29.8 (CH3CNCH3), 27.7 (NHCH3). Mp = 145-146 
°C. HRMS (ESI+): m/z calcd for C16H20N3O [M+H]
+ 270.1601, found 270.1625. 
 
(R)-1-(1-(4-fluorophenyl)-1-(pyridin-3-yl)ethyl)-1,3-dimethylurea (11b) 
 
Following general procedure 3, urea 7b (94 mg, 0.328 mmol), freshly prepared LDA (0.75 M in THF, 1.09 ml, 
0.819 mmol) and THF (3.3 ml) gave after purification by flash column chromatography (SiO2, 99:1 to 95:5 
CH2Cl2:MeOH), 11b as a white solid (70 mg, 74%). Rf 0.14 (95:5 CH2Cl2:MeOH). 
1H NMR (400 MHz, CDCl3) δ = 
8.59 – 8.35 (2H, m, 2 x =CH), 7.52 – 7.47 (1H, m, =CH), 7.23 – 7.15 (3H, m, 3 x =CH), 7.00 – 6.92 (2H, m, 2 x 
=CH), 4.24 (1H, dd, J = 8.7, 4.4, NHCH3), 2.79 (3H, s, CH3-C-N-CH3), 2.59 (3H, d, J = 4.6, NHCH3), 2.06 (3H, s, 
CH3-C-N-CH3). 
13C NMR (101 MHz, CDCl3) δ = 161.8 (d, 
1JCF = 247.2 Hz, =C-F), 159.6 (C=O), 148.3 (=CH), 147.8 
(=CH), 141.5 (=C), 140.5 (d, 4JCF = 3.4 Hz, =C), 134.5 (=CH), 128.8 (d, 
3JCF = 8.0 Hz, =CH), 123.3 (=CH), 115.6 (d, 
2JCF = 21.3 Hz, =CH), 65.8 (CH3C-N-CH3), 34.7 (CH3C-NCH3), 29.7 (CH3C-N-CH3), 27.7 (NHCH3). Mp = 126-127 
°C. []  
 
 = +10 (c = 1.00; CH2Cl2). IR (film, cm
-1): νmax = 3345, 2946, 1635, 1507, 1323, 1226, 1163, 1081, 814, 
728. HRMS (ESI+): m/z calcd for C16H19N3OF [M+H]
+ 288.1507, found 288.1492. 
 
  
                                                          
6
 Data in agreement with the literature (reference: Clayden, J.; Hennecke, U. Org. Lett. 2008, 10, 3567). 
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(R)-1-(1-(4-chlorophenyl)-1-(pyridin-3-yl)ethyl)-1,3-dimethylurea (11c) 
 
Following general procedure 3, urea 7c (91 mg, 0.298 mmol), freshly prepared LDA (0.75 M in THF, 0.99 ml, 
0.750 mmol) and THF (3.0 ml) gave after purification by flash column chromatography (SiO2, 99:1 to 95:5 
CH2Cl2:MeOH), 11c as a white solid (57 mg, 63%). Rf 0.12 (95:5 CH2Cl2:MeOH). 
1H NMR (400 MHz, CDCl3) δ = 
8.64 – 8.43 (2H, m, 2 x =CH), 7.56 (1H, ddd, J = 8.1, 2.3, 1.5, =CH), 7.33 – 7.19 (5H, m, 6 x =CH), 4.28 (1H, dd, 
J = 8.4, 4.1, NHCH3), 2.86 (3H, s, CH3C-NCH3), 2.67 (3H, d, J = 4.7 Hz, NHCH3), 2.12 (3H, s, CH3C-NCH3). 
13C 
NMR (101 MHz, CDCl3) δ = 159.6 (C=O), 148.4 (=CH), 148.0 (=CH), 143.5 (=C), 141.2 (=C), 134.5 (=C), 133.3 
(=CH), 128.9 (=CH), 128.5 (=CH), 123.3 (=CH), 65.9 (CH3C-NCH3), 34.8 (CH3C-NCH3), 29.4 (CH3C-NCH3), 27.7 
(NHCH3). Mp = 58-59 °C. []
  
 
 = +20 (c = 2.00; CH2Cl2). IR (film, cm
-1): νmax =3345, 2948, 1639, 1532, 1491, 
1415, 1326, 1095, 729. HRMS (ESI+): m/z calcd for C16H18N3OCl [M+H]
+ 304.1211, found 304.1207. 
 
(S)-1,3-dimethyl-1-(1-(pyridin-2-yl)-1-(pyridin-3-yl)ethyl)urea (11d) 
 
Following General procedure 3, urea 7d (92 mg, 0.302 mmol), freshly prepared LDA (0.75 M in THF, 1.01 ml, 
0.756 mmol) and THF (3.0 ml) gave after purification by flash column chromatography (SiO2, 99:1 to 95:5 
CH2Cl2:MeOH), 11d as a yellow oil (61 mg, 76%). Rf 0.10 (95:5 CH2Cl2:MeOH); 
1H NMR (400 MHz, CDCl3) δ = 
8.56 (1H, d, J = 2.4, =CH), 8.55 – 8.52 (1H, m, =CH), 8.47 (1H, dd, J = 4.7, 0.9, =CH), 7.72 – 7.64 (2H, m, 2 x 
=CH), 7.39 (1H, d, J = 8.1, =CH), 7.27 – 7.22 (1H, m, =CH), 7.17 (1H, dd, J = 7.4, 4.8, =CH), 5.00 (1H, br s, 
NHCH3), 3.01 (3H, s, CH3C-NCH3), 2.55 (3H, d, J = 4.6, NHCH3), 2.08 (3H, s, CH3C-NCH3). 
13C NMR (101 MHz, 
CDCl3) δ = 163.4 (=C), 159.7 (C=O), 149.0 (=CH), 148.5 (=CH), 148.0 (=CH), 140.4 (=C), 137.0 (=CH), 135.0 
(=CH), 123.0 (=CH), 122.1 (=CH), 121.5 (=CH), 66.9 (CH3C-NCH3), 33.5 (CH3C-NCH3), 28.9 (CH3C-NCH3), 27.5 
(NHCH3). Mp = 111-113 °C. IR (film, cm
-1): νmax = 3350, 2924, 1640, 1533, 1329, 1082, 714. HRMS (ESI
+): m/z 
calcd for C15H19N4O [M+H]
+ 271.1553, found 271.1541. 
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(S)-1-(1,2-diphenyl-1-(pyridin-3-yl)ethyl)-1,3-dimethylurea (11e) 
 
Following General procedure 3, urea 7e (85 mg, 0.246 mmol), freshly prepared LDA (0.75 M in THF, 0.82 ml, 
0.615 mmol) and THF (2.5 ml) gave after purification by flash column chromatography (SiO2, 99:1 to 95:5 
CH2Cl2:MeOH), 11e as a yellow solid (62 mg, 87%). Rf 0.19 (95:5 CH2Cl2:MeOH). 
1H NMR (400 MHz, CDCl3) δ 
= 8.62 – 8.31 (2H, m, 2 x  =CH), 7.60 (1H, d, J = 8.1 Hz, =CH), 7.38 – 7.08 (9H, m, 9 x =CH), 6.88 (2H, dd, J = 
7.9, 1.4, 2 x =CH), 4.36 (1H, dd, J = 9.0, 4.7, NHCH3), 4.19 – 4.11 (2H, m, CH2Ph), 2.72 (3H, d, J = 4.6, NHCH3), 
2.63 (3H, s, CH2C-NCH3). 
13C NMR (101 MHz, CDCl3) δ = 160.3 (C=O), 148.8 (=CH), 147.4 (=CH), 143.1 (=C), 
140.7 (=C), 137.1 (=C), 135.0 (=CH), 131.2 (=CH), 128.3 (=CH), 128.0 (2 x =CH), 127.2 (=CH), 126.8 (=CH), 71.3 
(NC-CH2), 43.4 (NC-CH2), 37.0 (CH2C-NCH3), 27.7 (NHCH3). Mp = 150-151 °C. []
  
 
 = +37 (c = 2.00; CH2Cl2). IR 
(film, cm-1): νmax = 3362, 2924, 1636, 1527, 1414, 1319. HRMS (ESI
+): m/z calcd for C22H24N3O [M+H]
+ 
346.1914, found 346.1899. 
 
(S)-1-(1-(3-chlorophenyl)-2-phenyl-1-(pyridin-3-yl)ethyl)-1,3-dimethylurea (11f) 
 
Following General procedure 3, urea 7f (87 mg, 0.230 mmol), freshly prepared LDA (0.75 M in THF, 0.76 ml, 
0.573mmol) and THF (2.3 ml) gave after purification by flash column chromatography (SiO2, 99:1 to 97:3 
CH2Cl2:MeOH), 11f as a yellow solid (19 mg, 22%). Rf 0.19 (95:5 CH2Cl2:MeOH). 
1H NMR (400 MHz, CDCl3) δ 
= 8.51 (1H, d, J = 1.0, =CH), 8.43 (1H, d, J = 4.1 Hz, =CH), 7.59 (1H, ddd, J = 8.1, 2.3, 1.5, =CH), 7.27 – 7.10 
(8H, m, 8 x =CH), 6.89 – 6.84 (2H, m, 2 x =CH), 4.51 (1H, dd, J = 9.3, 5.3, NHCH3), 4.13 (2H, s, CH2Ph), 2.75 
(3H, d, J = 4.6, NHCH3), 2.59 (3H, s, CH2C-NCH3). 
13C NMR (101 MHz, CDCl3) δ = 160.1 (C=O), 148.8 (=CH), 
147.7 (=CH), 145.8 (=C), 139.9 (=C), 136.7 (=C), 135.1 (=CH), 134.1 (=CH), 131.1 (=CH), 129.5 (=CH), 128.1 
(=CH), 127.9 (=CH), 127.2 (=CH), 126.9 (=CH), 125.8 (=CH), 122.9 (=CH), 71.0 (NCCH2), 43.0 (NCCH2), 37.2 
(CH2C-NCH3), 27.7 (NHCH3). Mp = 88-90 °C. []
  
 
 = +20 (c = 2.00; CH2Cl2). IR (film, cm
-1): νmax = 3349, 2953, 
1639, 1529, 1413, 1309, 907, 725, 700. HRMS (ESI+): m/z calcd for C22H23N3OCl [M+H]
+ 380.1524, found 
380.1520. 
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(S)-1-(1-(3-methoxyphenyl)-2-phenyl-1-(pyridin-3-yl)ethyl)-1,3-dimethylurea (11g) 
 
Following General procedure 3, urea 7g (68 mg, 0.181 mmol), freshly prepared LDA (0.75 M in THF, 0.61 ml, 
0.453 mmol) and THF (1.8 ml) gave after purification by flash column chromatography (SiO2, 99:1 to 97:3 
CH2Cl2:MeOH), 11g as a yellow solid (18 mg, 26%). Rf 0.15 (95:5 CH2Cl2:MeOH). 
1H NMR (500 MHz, CDCl3) δ 
= 8.52 (1H, br s, =CH), 8.40 (1H, br d, J = 4.1, =CH), 7.58 (1H, ddd, J = 8.0, 2.2, 1.5, =CH), 7.24 – 7.10 (5H, m,  
5 x =CH), 6.95 – 6.89 (3H, m, 3 x =CH), 6.85 (1H, t, J = 2.1, =CH), 6.76 (1H, dd, J = 8.2, 2.3, =CH), 4.37 (1H, dd, 
J = 8.5, 4.2, NHCH3), 4.15 (1H, d, J = 13.6, CHAHBPh), 4.11 (1H, d, J = 13.6, CHAHBPh), 3.70 (3H, s, OCH3), 2.72 
(3H, d, J = 4.6, NHCH3), 2.64 (3H, s, CH2C-NCH3). 
13C NMR (126 MHz, CDCl3) δ = 160.2 (C=O), 159.4 (=C-
OCH3), 148.9 (=CH), 147.5 (=CH), 144.9 (=C), 140.6 (=C), 137.2 (=C), 134.9 (=CH), 131.3 (=CH), 129.3 (=CH), 
128.1 (=CH), 126.8 (=CH), 122.7 (=CH), 120.3 (=CH), 114.6 (=CH), 112.1 (=CH), 71.2 (NC-CH2), 55.3 (OCH3), 
43.3 (NC-CH2), 37.2 (CH2C-NCH3), 27.7 (NHCH3). Mp = 71-73 °C. []
  
 
 = +10 (c = 1.00; CH2Cl2). IR (film, cm
-1): 
νmax = 3349, 2953, 1640, 1530, 1315, 724. HRMS (ESI
+): m/z calcd for C23H25N3O2Na [M+Na]
+ 398.1839, 
found 398.1842. 
 
(R)-1,3-dimethyl-1-(2-phenyl-1-(pyridin-2-yl)-1-(pyridin-3-yl)ethyl)urea (11h) 
 
Following General procedure 3, urea 7h (96 mg, 0.276 mmol), freshly prepared LDA (0.75 M in THF, 0.92 ml, 
0.691 mmol) and THF (2.8 ml) gave after purification by flash column chromatography (SiO2, 99:1 to 95:5 
CH2Cl2:MeOH), 11h as a yellow solid (84 mg, 88%). Rf 0.21 (95:5 CH2Cl2:MeOH). 
1H NMR (400 MHz, CDCl3) δ 
= 8.54 (1H, ddd, J = 4.8, 1.8, 0.9, =CH), 8.47 (1H, d, J = 2.2, =CH), 8.37 (1H, dd, J = 4.7, 1.4, =CH), 7.66 (1H, 
ddd, J = 8.1, 7.5, 1.9, =CH), 7.60 – 7.53 (2H, m, 2 x =CH), 7.20 – 7.06 (5H, m, 5 x =CH), 6.90 (2H, dd, J = 7.9, 
1.5, 2 x =CH), 4.71 (1H, dd, J = 8.5, 4.0, NHCH3), 4.28 (1H, d, J = 13.1, CHAHBPh), 4.04 (1H, d, J = 13.1, 
CHAHBPh), 2.73 (3H, d, J = 5.3, NHCH3), 2.64 (3H, d, J = 4.6, CH2C-NCH3). 
13C NMR (101 MHz, CDCl3) δ = 162.1 
(=C), 159.8 (C=O), 149.1 (=CH), 148.1 (=CH), 147.4 (=CH), 139.4 (=C), 137.0 (=C), 136.7 (=CH), 135.2 (=CH), 
131.2 (=CH), 128.1 (=CH), 126.8 (=CH), 123.0 (=CH), 122.5 (=CH), 122.1 (=CH), 71.9 (NCCH2), 42.5 (NCCH2), 
35.8 (CH2C-NCH3), 27.6 (NHCH3). Mp = 166-168 °C. []
  
 
 = +5 (c = 2.00; CH2Cl2). IR (film, cm
-1): νmax = 3349, 
2923, 1640, 1533, 1319, 730. HRMS (ESI+): m/z calcd for C21H23N4O [M+H]
+ 347.1866, found 347.1851. 
32 
 
1-(4-fluorophenyl)-N-methyl-1-(pyridin-3-yl)ethan-1-amine (12b) 
 
Following General procedure 4, urea 11b (32 mg, 0.111 mmol), 10% aqueous NaOH solution (0.45 mL, 1.11 
mmol), EtOH (0.89 mL) gave 12b as a yellow oil (23 mg, 88%) without further purification. 1H NMR (500 
MHz, CDCl3) δ = 8.61 (1H, d, J = 2.0, =CH), 8.47 (1H, dd, J = 4.7, 1.3, =CH), 7.63 (1H, ddd, J = 8.0, 2.3, 1.7, 
=CH), 7.33 – 7.27 (2H, m, 2 x =CH), 7.22 (1H, ddd, J = 8.1, 4.7, 0.5, =CH), 7.03 – 6.95 (2H, m, 2 x =CH), 2.20 
(3H, s, N-C-CH3), 1.79 (3H, s, NHCH3). 
13C NMR (126 MHz, CDCl3) δ = 161.7 (d, 
1JCF = 245.2 Hz, =CF), 149.0 
(=CH), 148.0 (=CH), 143.1 (=C), 142.5 (d, 4JCF = 3.1 Hz, =C), 134.8 (=CH), 128.8 (d, 
3JCF = 7.7 Hz, =CH), 123.1 
(=CH), 115.1 (d, 2JCF = 20.4 Hz, =CH), 61.5 (CH3NH-C-CH3), 29.8 (CH3NH-C-CH3), 26.9 (CH3NH-C-CH3). IR (film, 
cm-1): νmax = 3289, 2981, 1506, 1414. []
  
 
 = -5.0 (c = 1.00; CH2Cl2). HRMS (ESI
+): m/z calcd for C14H16N2F 
[M+H]+ 231.1292, found 231.1289. 
 
(R)-1-(4-fluorophenyl)-N-methyl-1-(pyridin-3-yl)ethan-1-amine (12d) 
 
Following general procedure 4, urea 11d (27 mg, 0.098 mmol), 10% aqueous NaOH solution (0.39 mL, 0.98 
mmol), EtOH (0.78 mL) gave 12d as a yellow oil (14 mg, 64%) without further purification. 
1H NMR (500 MHz, CDCl3) δ = 8.58 – 8.47 (2H, m, 2 x =CH), 8.42 – 8.35 (1H, m, =CH), 7.66 (1H, dq, J = 8.1, 
1.8, =CH), 7.55 (1H, tt, J = 7.8, 1.7, =CH), 7.22 – 7.13 (2H, m, 2 x =CH), 7.10 – 7.06 (1H, m, =CH), 2.16 (3H, s, 
N-C-CH3), 1.79 (3H, s, NHCH3). 
13C NMR (126 MHz, CDCl3) δ = 165.1 (=C), 149.2 (=CH), 149.1 (=CH), 148.0 
(=CH), 142.4 (=C), 136.5 (=CH), 134.9 (=CH), 123.2 (=CH), 121.9 (=CH), 121.6 (=CH), 63.1 (CH3NH-C-CH3), 29.7 
(CH3NH-C-CH3), 25.1 (CH3NH-C-CH3). IR (film, cm
-1): νmax = 3304, 2983, 2923, 1587, 1430, 1414. []
  
 
 = +8.7 
(c = 1.00; CH2Cl2). HRMS (ESI
+): m/z calcd for C13H16N3 [M+H]
+ 214.1339, found 214.1324. 
 
(R)-1-(4-methoxybenzyl)-3-methyl-1-(1-phenyl-1-(pyridin-3-yl)ethyl)urea (13) 
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Following General procedure 3, urea 9 (0.995 g, 2.65 mmol), freshly prepared LDA (0.75 M in THF, 8.84 ml, 
6.627 mmol) and THF (26.5 ml) gave after purification by flash column chromatography (SiO2, 99:1 to 95:5 
CH2Cl2:MeOH), 13 as a yellow solid (0.845 g, 85%). Rf 0.26 (95:5 CH2Cl2:MeOH); 
1H NMR (500 MHz, CDCl3) δ 
= 8.54 (1H, d, J = 2.5, =CH), 8.39 (1H, dd, J = 4.7, 1.5, =CH), 7.48 (1H, ddd, J = 8.1, 2.5, 1.5, =CH), 7.27 – 7.10 
(8H, m, 8 x =CH), 6.86 – 6.80 (2H, m, 2 x =CH), 4.44 (1H, d, J = 17.5, NHCHAHB), 4.35 (1H, d, J = 17.5 Hz, 
NHCHAHB), 4.24 (1H, q, J = 4.7 Hz, CH-CH3), 3.75 (3H, s, OCH3), 2.51 (3H, d, J = 4.5, CH-CH3), 2.02 (3H, s, 
NCH3). 
13C NMR (101 MHz, CDCl3) δ =  160.3 (=C), 158.8 (=C), 148.8 (=CH), 147.8 (=CH), 144.2 (=C), 141.6 
(=C), 134.9 (=CH), 131.5 (=CH), 128.6 (=CH), 127.5 (3x =CH), 123.0 (=CH), 114.4 (=CH), 67.2 (NH-C-CH3), 55.4 
(OCH3), 50.5 (NHCH2), 31.0 (NH-C-CH3), 27.7 (NHCH3). Mp = 56-58 °C. []
  
 
 = +0.25 (c = 1.00; CH2Cl2). IR 
(film, cm-1): νmax = 3440, 2951, 1645, 1510, 1243. HRMS (ESI
+): m/z calcd for C23H26N3O2 [M+H]
+ 376.2020, 
found 376.2003.  
 
1-[(1R)-1-(3-Chlorophenyl)-1-(pyridine-2-yl)ethyl]-1,3-dimethylurea (14a) 
 
Following general procedure 3, LDA (0.21 ml), urea 8a (50 mg, 0.17 mmol) and THF (1.56 ml) gave, after 
purification by flash column chromatography (SiO2, 99:1 to 90:10 DCM:MeOH), 14a as an oil (48 mg, 96%). 
1H NMR (400 MHz, CDCl3) δ = 8.58-8.49 (1H, m, =CH), 7.69-7.58 (1H, m, =CH), 7.37-7.09 (6H, m, 6 x =CH), 
5.08-4.85 (1H, brs, NHCH3), 2.95 (3H, s, NCH3), 2.55 (3H, d, J = 4.6, NHCH3), 2.06 (3H, s, CH3). 
13C NMR (100 
MHz, CDCl3) δ = 163.5 (C=O), 159.9 (=C), 148.4 (=CH), 147.2 (=C), 136.8 (=CH), 134.1 (=C), 129.5 (=CH), 127.5 
(=CH), 127.1 (=CH), 125.5 (=CH), 121.9 (=CH), 121.5 (=CH), 68.1 (NC), 33.7 (NCH3), 28.6 (NCH3), 27.4 (CH3). 
[]  
 
 = -53 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 3337, 2980, 2935, 1630. HRMS (ESI
+): m/z calcd for 
C16H18ClN3ONa [M+Na]
+ 326.1036, found 326.1043. 
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1,3-Dimethyl-1-[(1R)-1-phenyl-1(pyridin-2-yl)propyl]urea (14b) 
 
Following general procedure 3, LDA (0.44 ml), urea 8b (100 mg, 0.35 mmol) and THF (3.53 ml) gave, after 
purification by flash column chromatography (SiO2, 99:1 to 90:10 DCM:MeOH), 14b as an oil (88 mg, 88%). 
1H NMR (400 MHz, CDCl3) δ = 8.58-8.53 (1H, m, =CH), 7.69 (1H, td, J = 7.9 and 1.8, =CH), 7.52-7.44 (1H, m, 
=CH), 7.35-7.27 (4H, m, 4 x =CH), 7.24-7.14 (2H, m, 2 x =CH), 5.82-5.63 (1H, m, NHCH3), 3.03 (3H, m, NCH3), 
2.65-2.52 (2H, m, CH2CH3), 2.51 (3H, d, J = 4.6, NHCH3), 0.76 (3H, t, J = 7.3, CH2CH3). 
13C NMR (100 MHz, 
CDCl3) δ = 162.6 (C=O), 160.3 (=C), 148.3 (=CH), 142.8 (=C), 136.6 (=CH), 128.3 (2 x =CH), 127.7 (=CH), 126.8 
(=CH), 122.0 (=CH), 70.9 (NC), 33.5 (NCH3), 33.1 (CH2), 27.3 (NCH3), 10.1 (CH3). []
  
 
 = -80 (c = 1.00; CHCl3). 
IR (film, cm-1): νmax = 3341, 2970, 2937, 1635. HRMS (ESI
+): m/z calcd for C17H21N3ONa [M+Na]
+ 306.1577, 
found 306.1581. 
 
1,3-Dimethyl-1-[(1R)-1-phenyl-1(pyridin-2-yl)but-3-en-1-yl]urea (14c) 
 
Following general procedure 3, LDA (0.42 ml), urea 8c (100 mg, 0.34 mmol) and THF (3.39 ml) gave, after 
purification by flash column chromatography (SiO2, 99:1 to 90:10 DCM:MeOH), 14c as an oil (67 mg, 67%). 
1H NMR (400 MHz, CDCl3) δ = 8.59-8.46 (1H, m, =CH), 7.63 (1H, td, J = 8.0 and 1.8, =CH), 7.44 (1H, d, J = 8.1, 
=CH), 7.38-7.31 (2H, m, 2 x =CH), 7.30-7.23 (2H, m, 2 x =CH), 7.22-7.16 (1H, m, =CH), 7.12 (1H, ddd, J = 7.4, 
4.8 and 0.8, =CH), 5.71 (1H, ddt, J = 17.1, 10.2 and 6.9, CH2=CHCH2), 5.23-5.08 (1H, m, NHCH3), 5.08-4.91 
(2H, m, =CH2) 3.51 (1H, dd, J = 14.6 and 6.8, CHACHBCH=), 3.41 (1H, dd, J = 14.6 and 7.0, CHACHBCH=), 2.97 
(3H, s, NCH3), 2.56 (3H, d, J = 4.6, NHCH3). 
13C NMR (100 MHz, CDCl3) δ = 163.2 (C=O), 160.1 (=C), 148.3 
(=CH), 143.0 (=C), 136.3 (=CH), 134.7 (=CH), 128.1 (=CH), 128.0 (=CH), 127.0 (=CH), 122.1 (=CH), 121.7 (=CH), 
118.3 (=CH2), 71.0 (NC), 44.0 (CH2), 34.9 (CH3), 27.4 (NCH3). []
  
 
 = -36 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 
3345, 3060, 2925, 1635, 1218, 1081. HRMS (ESI+): m/z calcd for C18H21N3ONa [M+Na]
+ 318.1577, found 
318.1577. 
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1-[(4-Methoxyphenyl)methyl]- 3-methyl-1-[(1R)-1-phenyl-1-(pyridin-2-yl)ethyl]urea (15a) 
 
Following General procedure 3, LDA (0.48 ml), urea 10a (145 mg, 0.39 mmol) and THF (3.86 ml) gave, after 
purification by flash column chromatography (SiO2, 99:1 to 90:10 DCM:MeOH), 15a as an oil (138 mg, 95%). 
1H NMR (400 MHz, CDCl3) δ = 8.62-8.50 (1H, m, =CH), 7.59 (1H, td, J = 7.9 and 1.8, =CH), 7.35-7.18 (8H, m,  
8 x =CH), 7.15 (1H, ddd, J = 7.4, 4.9 and 0.7, =CH), 6.89-6.79 (2H, m, 2 x =CH), 5.42-5.26 (1H, m, NHCH3), 
4.77 (1H, d, J = 17.0, NCHAHB), 4.49 (1H, d, J = 17.1, NCHAHB), 3.81 (3H, s, OCH3), 2.51 (3H, d, J = 4.6, NHCH3), 
2.04 (3H, s, CH3). 
13C NMR (100 MHz, CDCl3) δ = 164.4 (C=O), 160.7 (=C), 158.5 (=C), 148.2 (=CH), 145.1 (=C), 
136.5 (=CH), 132.7 (=C), 128.2 (=CH), 128.1 (=CH), 127.4 (2 x =CH), 127.0 (=CH), 122.2 (=CH), 121.8 (=CH), 
114.0 (=CH), 69.2 (NC), 55.4 (OCH3), 49.7 (CH2), 30.8 (NCH3), 27.5 (CH3). []
  
 
 = -44 (c = 1.00; CHCl3). IR (film, 
cm-1): νmax = 2990, 2937, 1641. HRMS (ESI
+): m/z calcd for C23H26N3O2 [M+H]
+ 376.2025, found 376.2025. 
 
1-[(4-Methoxyphenyl)methyl]-3-methyl-1-[(1R)-1-(4-methylphenyl)-1-(pyridin-2-yl)ethyl]urea (15b) 
N
N
CH3 O
N
H
OCH3  
Following general procedure 3, LDA (0.14 ml), urea 10b (45 mg, 0.12 mmol) and THF (1.16 ml) gave, after 
purification by flash column chromatography (SiO2, 99:1 to 90:10 DCM:MeOH), 15b as an oil (44 mg, 98%). 
1H NMR (400 MHz, CDCl3) δ = 8.55 (1H, ddd, J = 4.8, 1.9 and 0.7, =CH), 7.58 (1H, td, J = 7.7 and 1.8, =CH), 
7.33-7.27 (3H, m, 3 x =CH), 7.16-7.11 (3H, m, 3 x =CH), 7.10-7.04 (2H, m, 2 x =CH), 6.89-6.81 (2H, m, 2 x 
=CH), 5.18 (1H, q, J = 4.6, NHCH3), 4.76 (1H, d, J = 17.0, NCHAHB), 4.47 (1H, d, J = 17.0, NCHAHB), 3.80 (3H, s, 
OCH3), 2.51 (3H, d, J = 4.6, NHCH3),  2.31 (3H, s, CH3), 2.03 (3H, s, CH3). 
13C NMR (100 MHz, CDCl3) δ = 164.6 
(C=O), 160.7 (=C), 158.5 (=C), 148.2 (=CH), 141.9 (=C), 136.7 (=CH), 136.4 (=C), 132.8 (=C), 128.9 (=CH), 128.2 
(=CH), 127.4 (CH), 122.2 (=CH), 121.7 (=CH), 114.0 (=CH), 69.1 (NC), 55.4 (OCH3), 49.8 (CH2), 30.7 (NCH3), 
27.5 (CH3), 21.1 (CH3). []
  
 
 = -48 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 2924, 1641, 1243, 1034, 748. HRMS 
(ESI+): m/z calcd for C24H27N3O2Na [M+Na]
+ 412.1995, found 412.1994. 
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1-[(1R)-1-(3-Methoxyphenyl)-1-(pyridin-2-yl)ethyl]-1-[(4-[methoxyphenyl)methyl]-3-methylurea (15c) 
 
Following general procedure 3, LDA (0.19 ml), urea 10c (63 mg, 0.16 mmol) and THF (1.55 ml) gave, after 
purification by flash column chromatography (SiO2, 99:1 to 90:10 DCM:MeOH), 15c as an oil (64 mg, 98%). 
1H NMR (400 MHz, CDCl3) δ = 8.57 (1H, dd, J = 4.7 and 0.9, =CH), 7.59 (1H, td, J = 7.9 and 1.8, =CH), 7.36-
7.24 (3H, m, 3 x =CH), 7.18 (1H, t, J = 8.0, =CH), 7.14 (1H, dd, J = 7.4 and 5.5, =CH), 6.90-6.70 (5H, m, 5 x 
=CH), 5.37-5.22 (1H, brq, NHCH3), 4.69 (1H, d, J = 17.0, NCHAHB), 4.51 (1H, d, J = 17.1, NCHAHB), 3.80 (3H, s, 
OCH3), 3.70 (3H, s, OCH3), 2.53 (3H, d, J = 4.6, NHCH3), 2.06 (3H, s, CH3). 
13C NMR (100 MHz, CDCl3) δ = 164.2 
(C=O), 160.6 (=C), 159.4 (=C), 159.5 (=C), 148.3 (=CH), 147.0 (=C), 136.4 (=CH), 132.6 (=C), 129.1 (=CH), 128.1 
(2 x =CH), 122.1 (=CH), 121.8 (=CH), 119.8 (=CH), 114.0 (2 x =CH), 113.7 (=CH), 112.1 (=CH), 69.3 (NC), 55.4 
(OCH3), 55.2 (OCH3), 49.9 (CH2), 30.4 (NCH3), 27.5 (CH3). []
  
 
 = -28 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 
2957, 2924, 1670, 1250, 1034. HRMS (ESI+): m/z calcd for C24H28N3O3 [M+ H]
+ 406.2125, found 406.2111. 
 
1-[(1R)-1-(4-Chlorophenyl)-1-(pyridin-2-yl)ethyl]-1-[(4-[methoxyphenyl)methyl]-3-methylurea (15d) 
 
Following general procedure 3, LDA (0.13 ml), urea 10d (41 mg, 0.10 mmol) and THF (1.00 ml) gave, after 
purification by flash column chromatography (SiO2, 99:1 to 90:10 DCM:MeOH), 15d as an oil (35 mg, 85%). 
1H NMR (400 MHz, CDCl3) δ = 8.55 (1H, ddd, J = 4.8, 1.9 and 0.9, =CH), 7.59 (1H, td, J = 7.6 and 1.9, =CH), 
7.32-7.17 (7H, m, 7 x =CH), 7.15 (1H, ddd, J =7.5, 4.8 and 0.8, =CH), 6.92-6.76 (2H, m, 2 x =CH), 5.34 (1H, q, J 
= 4.5, NHCH3), 4.76 (1H, d, J = 17.1, NCHAHB), 4.44 (1H, d, J = 17.1, NCHAHB), 3.80 (3H, s, OCH3), 2.53 (3H, d, J 
= 4.6, NHCH3), 2.01 (3H, s, CH3). 
13C NMR (100 MHz, CDCl3) δ = 164.0 (C=O), 160.5 (=C), 158.7 (=C), 148.4 
(=CH), 143.8 (=C), 136.6 (=CH), 132.7 (=C), 132.3 (=C), 128.9 (2 x =CH), 128.2 (2 x =CH), 128.1 (2 x =CH), 
122.1 (=CH), 122.0 (=CH), 114.1 (2 x =CH), 68.8 (NC), 55.4 (OCH3), 49.7 (CH2), 30.5 (NCH3), 27.5 (CH3). []
  
 
 = 
+16 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 2980, 1642, 1215, 1038, 747. HRMS (ESI
+): m/z calcd for 
C23H24ClN3O2Na [M+Na]
+ 432.1449, found 432.1437. 
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1-[(1R)-1-(3-Chlorophenyl)-1-(pyridin-2-yl)ethyl]-1-[(4-[methoxyphenyl)methyl]-3-methylurea (15e) 
 
Following general procedure 3, LDA (0.21 ml), urea 10e (70 mg, 0.17 mmol) and THF (1.71 ml) gave, after 
purification by flash column chromatography (SiO2, 99:1 to 90:10 DCM:MeOH), 15e as an oil (67 mg, 96%). 
1H NMR (400 MHz, CDCl3) δ = 8.62-8.51 (1H, m, =CH), 7.60 (1H, td, J = 7.9 and 1.7, =CH), 7.35-7.23 (8H, m, 8 
x =CH), 6.90-6.80 (2H, m, 2 x =CH), 5.47-5.34 (1H, m, NHCH3), 4.76 (1H, d, J = 17.1, NCHAHB), 4.45 (1H, d, J = 
17.1, NCHAHB), 3.80 (3H, s, OCH3), 2.53 (3H, d, J = 4.6, NHCH3), 2.01 (3H, m, CH3). 
13C NMR (100 MHz, CDCl3) 
δ = 163.4 (C=O), 160.4 (=C), 158.6 (=C), 148.3 (=CH), 147.4 (=C), 136.7 (=CH), 134.0 (=C), 132.2 (=C), 129.4 
(=CH), 128.1 (2 x =CH), 127.6 (=CH), 127.1 (=CH), 125.6 (=CH), 122.2 (=CH), 122.1 (=CH), 114.1 (2 x =CH), 
68.9 (NC), 55.4 (OCH3), 49.7 (CH2), 30.5 (NCH3), 27.5 (CH3). []
  
 
 = -53 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 
2985, 1653, 1207, 1036, 751.  HRMS (ESI+): m/z calcd for C23H25ClN3O2 [M+H]
+ 410.1635, found 410.1637. 
 
1-[(1R)-1-(2-Chlorophenyl)-1-(pyridin-2-yl)ethyl]-1-[(4-[methoxyphenyl)methyl]-3-methylurea (15f) 
 
Following general procedure 3, LDA (0.23 ml), urea 10f (74 mg, 0.18 mmol) and THF (1.81 ml) gave, after 
purification by flash column chromatography (SiO2, 99:1 to 90:10 DCM:MeOH), 15f as an oil (49 mg, 66%). 
1H NMR (400 MHz, CDCl3) δ = 8.56-8.38 (1H, m, =CH), 7.61-7.51 (1H, m, =CH), 7.38-7.31 (1H, m, =CH), 7.27-
7.17 (6H, m, 6 x =CH), 7.16-7.10 (1H, m, =CH), 6.87-6.71 (2H, m, 2 x =CH), 6.23-6.02 (1H, m, NHCH3), 5.11 
(1H, d, J = 16.9, NCHAHB), 4.45 (1H, d, J = 16.9, NCHAHB), 3.80-3.75 (3H, m, OCH3), 2.59-2.46 (3H, m, NHCH3), 
2.21-2.07 (3H, m, CH3). 
13C NMR (100 MHz, CDCl3) δ = 162.5 (C=O), 160.4 (=C), 158.4 (=C), 147.2 (=CH), 
141.9 (=C), 136.7 (=CH), 132.9 (=C), 132.8 (=C), 132.0 (=CH), 129.0 (=CH), 128.3 (=CH), 128.2 (2 x =CH), 126.7 
(=CH), 122.9 (=CH), 122.2 (=CH), 113.9 (2 x =CH), 69.4 (NC), 55.4 (OCH3), 49.3 (CH2), 27.4 (NCH3), 27.3 (CH3). 
[]  
 
 = -28 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 3017, 1628, 1215, 1035, 745. HRMS (ESI
+): m/z calcd for 
C23H24ClN3O2Na [M+Na]
+ 432.1449, found 432.1447. 
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1-[(1R)-1-(4-Cyanophenyl)-1-(pyridin-2-yl)ethyl]-1-[(4-[methoxyphenyl)methyl]-3-methylurea (15g) 
 
Following general procedure 3, LDA (0.24 ml), urea 10g (78 mg, 0.20 mmol) and THF (1.95 ml) gave, after 
purification by flash column chromatography (SiO2, 99:1 to 90:10 DCM:MeOH), 15g as an oil (66 mg, 85%). 
1H NMR (400 MHz, CDCl3) δ = 8.57 (1H, ddd, J = 4.8, 1.9 and 0.9, =CH), 7.55 (1H, ddd, J = 9.4, 7.5 and 1.9, 
=CH), 7.58-7.53 (2H, m, 2 x =CH), 7.41-7.35 (2H, m, 2 x =CH), 7.32-7.26 (3H, m, 3 x =CH), 7.18 (1H, ddd, J 
=7.5, 4.8 and 1.0, =CH), 6.89-6.83 (2H, m, 2 x =CH), 5.46 (1H, q, J = 4.3, NHCH3), 4.73 (1H, d, J = 17.3, 
NCHAHB), 4.42 (1H, d, J = 17.3, NCHAHB), 3.81 (3H, s, OCH3), 2.53 (3H, d, J = 4.6, NHCH3), 2.01 (3H, s, CH3). 
13C 
NMR (100 MHz, CDCl3) δ = 162.9 (C=O), 160.3 (=C), 158.8 (=C), 151.4 (=C), 148.4 (=CH), 136.8 (=CH), 131.9 
(2 x =CH), 131.7 (=C), 128.0 (2 x =CH), 127.9 (2 x =CH), 122.4 (=CH), 122.3 (=CH), 119.1 (=C), 114.3 (2 x =CH), 
110.4 (CN), 69.1 (NC), 55.5 (OCH3), 49.7 (CH2), 30.1 (NCH3), 27.4 (CH3). []
  
 
 = -56 (c = 1.00; CHCl3). IR (film, 
cm-1): νmax = 2999, 2227, 1647, 1244, 1033, 749. HRMS (ESI
+): m/z calcd for C24H24N4O2Na [M+Na]
+ 
423.1791, found 423.1793. 
 
1-[(4-Methoxyphenyl)methyl]-3-methyl-1-[(1R)-1-phenyl-1-(pyridin-2-yl)but-3-en-1-yl]urea (15h) 
 
Following general procedure 3, LDA (0.24 ml), urea 10h (77 mg, 0.19 mmol) and THF (1.92 ml) gave, after 
purification by flash column chromatography (SiO2, 99:1 to 90:10 DCM:MeOH), 15h as an oil (70 mg, 91%). 
1H NMR (400 MHz, CDCl3) δ = 8.58-8.50 (1H, m, =CH), 7.54 (1H, td, J = 8.0 and 1.9, =CH), 7.34-7.29 (1H, m, 
=CH), 7.28-7.15 (7H, m, 7 x =CH), 6.85-6.76 (2H, m, 2 x =CH), 7.22-7.16 (1H, m, =CH), 7.12 (1H, ddd, J = 7.4, 
4.8 and 0.9, =CH), 5.76-5.67 (1H, m, NHCH3), 5.59 (1H, ddt, J = 17.1, 10.2 and 6.8, CH2=CHCH2), 5.03-4.87 
(2H, m, =CH2) 3.80 (3H, s, OCH3), 3.49 (1H, dd, J = 14.5 and 6.8, CHACHBCH=), 3.40 (1H, dd, J = 14.5 and 7.5, 
CHACHBCH=), 2.52 (3H, d, J = 4.6, NHCH3). 
13C NMR (100 MHz, CDCl3) δ = 163.3 (C=O), 160.6 (=C), 158.5 (=C) 
148.1 (=CH), 143.1 (=C), 136.1 (=CH), 134.8 (=CH), 132.4 (=C), 128.1 (2 x =CH), 128.0 (2 x =CH), 127.8 (2 x 
=CH), 126.9 (=CH), 122.7 (=CH), 121.7 (=CH), 118.3 (=CH2),  114.0 (2 x =CH), 71.8 (NC), 55.4 (OCH3), 50.3 
(CH2), 44.8 (CH2), 27.4 (NCH3). []
  
 
 = -36 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 3441, 3064, 2930, 1645, 
1244, 1036. HRMS (ESI+): m/z calcd for C25H28N3O2 [M+H]
+ 402.2182, found 402.2174. 
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[(4-[Methoxyphenyl)methyl][(1R)-1-phenyl-1-(pyridin-2-yl)ethyl]amine (16a) 
 
Following general procedure 4, urea 15a (130 mg, 0.35 mmol) gave 16a as an oil (100 mg, 91%). 1H NMR 
(400 MHz, CDCl3) δ = 8.61-8.53 (1H, m, =CH), 7.58 (1H, td, J = 7.8 and 1.9, =CH), 7.53-7.46 (2H, m, 2 x =CH), 
7.35-7.29 (2H, m, 2 x =CH), 7.28-7.25 (3H, m, 3 x =CH), 7.25-7.19 (1H, m, =CH), 7.11 (1H, ddd, J = 7.5, 4.8 
and 1.1, =CH), 6.92-6.78 (2H, m, 2 x =CH), 3.79 (3H, s, OCH3), 3.50 (2H, AB pattern, J = 12.2, Δν = 18.8, 
NHCH2), 2.95-2.21 (1H, brs, NHCH2), 1.95 (3H, s, CH3). 
13C NMR (100 MHz, CDCl3) δ = 166.4 (=C), 158.6 (=C), 
148.8 (=CH), 147.1 (=C), 136.3 (=CH), 133.6 (=C), 129.5 (2 x =CH), 128.3 (2 x =CH), 127.3 (2 x =CH), 126.7 
(=CH), 121.7 (=CH), 121.5 (=CH), 113.9 (2 x =CH), 64.3 (NC), 55.4 (OCH3), 46.9 (CH2), 26.2 (CH3). []
  
 
 = -49 (c 
= 1.00; CHCl3). IR (film, cm
-1): νmax = 2.954, 2931, 1241. HRMS (ESI
+): m/z calcd for C21H23N2O1 [M+H]
+ 
319.1805, found 319.1809. 
 
[(4-[Methoxyphenyl)methyl][(1R)-1-(4-methylphenyl)-1-(pyridin-2-yl)ethyl]amine (16b) 
 
Following general procedure 4, urea 15b (37 mg, 0.09 mmol) gave 16b as an oil (28 mg, 90%). 1H NMR (400 
MHz, CDCl3) δ = 8.63-8.50 (1H, m, =CH), 7.63-7.50 (1H, m, =CH), 7.42-7.32 (2H, m, 2 x =CH) , 7.30-7.21 (3H, 
m, 3 x =CH), 7.17-7.03 (3H, m, 3 x =CH), 6.89-6.77 (2H, m, 2 x =CH), 3.79 (3H, s, OCH3), 3.50 (2H, AB pattern, 
J = 12.1, Δν = 12.6, NHCH2), 2.73-2.37 (1H, brs, NH), 2.32 (3H, s, CH3), 1.93 (3H, s, CH3). 
13C NMR (100 MHz, 
CDCl3) δ = 166.4 (=C), 158.6 (=C), 148.7 (=CH), 143.9 (=C), 136.3 (=CH), 136.2 (=C), 133.5 (=C), 129.5 (2 x 
=CH), 129.0 (2 x =CH), 127.2 (2 x =CH), 121.6 (=CH), 121.5 (=CH), 113.8 (2 x =CH), 64.1 (NC), 55.4 (OCH3), 
46.9 (CH2), 26.2 (CH3), 21.1 (CH3). []
  
 
 = -24 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 2926, 1246, 1036. HRMS 
(ESI+): m/z calcd for C22H25N2O [M+H]
+ 333.1961, found 333.1961. 
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[(1R)-1-(3-Methoxyphenyl)-1-(pyridin-2-yl)ethyl][(4-[methoxyphenyl)methyl]amine (16c) 
 
Following general procedure 4, urea 15c (57 mg, 0.14 mmol) gave 16c as an oil (28 mg, 90%). 1H NMR (400 
MHz, CDCl3) δ = 8.61-8.54 (1H, m, =CH), 7.58 (1H, td, J = 7.9 and 1.8, =CH), 7.32-7.20 (4H, m, 4 x =CH), 7.15-
7.10 (2H, m, 2 x =CH) , 7.09-7.02 (1H, m, =CH), 6.89-6.82 (2H, m, 2 x =CH), 6.78 (1H, ddd, J = 7.1, 1.5 and 0.6, 
=CH), 3.80 (3H, s, OCH3), 3.78 (3H, s, OCH3), 3.51 (2H, AB pattern, J = 15.5, Δν = 18.4, NHCH2), 2.58-2.31 (1H, 
brs, NH), 1.94 (3H, s, CH3). 
13C NMR (100 MHz, CDCl3) δ = 166.1 (=C), 159.6 (=C), 158.6 (=C), 148.8 (=C), 
148.7 (=CH), 136.3 (=CH), 133.5 (=C), 129.5 (2 x =CH), 129.2 (=CH), 121.6 (=CH), 121.5 (=CH), 119.9 (=CH), 
113.8 (2 x =CH), 113.5 (=CH), 111.8 (=CH), 64.2 (NC), 55.4 (OCH3), 55.3 (OCH3), 46.9 (CH2), 26.2 (CH3). []
  
 
 = 
-9.4 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 3011, 2960, 1246, 1037. HRMS (ESI
+): m/z calcd for C22H25N2O2 
[M+H]+ 349.1911, found 349.1914. 
 
[(1R)-1-(4-Chlorophenyl)-1-(pyridin-2-yl)ethyl][(4-[methoxyphenyl)methyl]amine (16d) 
 
Following general procedure 4, urea 15d (30 mg, 0.07 mmol) gave 16d as an oil (25 mg, 97%). 1H NMR (400 
MHz, CDCl3) δ = 8.65-8.50 (1H, m, =CH), 7.60 (1H, td, J = 7.6 and 1.4, =CH), 7.49-7.39 (2H, m, 2 x =CH), 7.30-
7.22 (5H, m, 5 x =CH) , 7.13 (1H, dd, J = 7.1 and 4.9, =CH), 6.92-6.76 (2H, m, 2 x =CH), 3.79 (3H, s, OCH3), 
3.48 (2H, AB pattern, J = 12.1, Δν = 15.9, NHCH2), 2.71-2.40 (1H, brs, NH), 1.92 (3H, s, CH3). 
13C NMR (100 
MHz, CDCl3) δ = 165.8 (=C), 158.7 (=C), 149.0 (=CH), 145.7 (=C), 136.4 (=CH), 133.2 (=C), 132.5 (=C), 129.4 (2 
x =CH), 128.8 (2 x =CH), 128.4 (2 x =CH), 121.7 (=CH), 121.4 (=CH), 113.9 (2 x =CH), 64.0 (NC), 55.4 (OCH3), 
46.9 (CH2), 26.2 (CH3). []
  
 
 = -48 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 3002, 2934, 1238, 1042, 767. HRMS 
(ESI+): m/z calcd for C21H22ClN2O [M+H]
+ 353.1415, found 353.1421. 
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[(1R)-1-(2-Chlorophenyl)-1-(pyridin-2-yl)ethyl][(4-[methoxyphenyl)methyl]amine (16e) 
 
Following general procedure 4, urea 15f (41 mg, 0.10 mmol) gave 16e as an oil (32 mg, 91%). 1H NMR (400 
MHz, CDCl3) δ = 8.56-8.46 (1H, m, =CH), 7.87 (1H, d, J = 7.9, =CH), 7.60 (1H, td, J = 8.0 and 1.7, =CH), 7.46 
(1H, d, J = 8.0, =CH), 7.39-7.33 (1H, m, =CH), 7.32-7.28 (1H, m, =CH), 7.27-7.23 (1H, m, =CH), 7.22-7.16 (2H, 
m, 2 x =CH), 7.15-7.06 (1H, m, =CH), 6.89-6.75 (2H, m, 2 x =CH), 3.78 (3H, s, OCH3), 3.54 (1H, d, J = 12.0, 
NHCHAHB), 3.28 (1H, d, J = 12.0, NHCHAHB), 2.98-2.59 (1H, brs, NH), 1.91 (3H, s, CH3). 
13C NMR (100 MHz, 
CDCl3) δ = 166.4 (=C), 158.7 (=C), 157.5 (=C), 148.7 (=CH), 146.2 (=C), 136.2 (=CH), 133.3 (=C), 131.5 (=CH), 
129.6 (3 x =CH), 128.5 (=CH), 126.8 (=CH), 121.4 (=CH), 121.1 (=CH), 113.9 (2 x =CH), 65.3 (NC), 55.4 (OCH3), 
47.1 (CH2), 26.7 (CH3). []
  
 
 = -36 (c = 1.00; CHCl3). IR (film, cm
-1): νmax = 2929, 1245, 1034, 750. HRMS (ESI
+): 
m/z calcd for C21H22ClN2O1 [M+H]
+ 353.1415, found 353.1416. 
 
4-[(1R)-1-{[(4-Methoxyphenyl)methyl]amino}-1-(pyridin-2-yl)ethyl]benzoic acid (16f) 
 
A solution of urea 15g (62 mg, 0.16 mmol), aqueous NaOH (2.0 M) and EtOH (1.2 M) was microwaved at 
130 °C for 3 h. The reaction mixture was concentrated and extracted with ethyl acetate. The aqueous phase 
was acidified with conc. HCl (pH = 1) and concentrated under reduced pressure. The amine 16f was 
obtained by filtration on acidic Dowx ion exchange column (32 mg, 57%). 1H NMR (400 MHz, MeOD) δ = 
8.78-8.66 (1H, m, =CH), 8.10-7.95 (2H, m, 2 x =CH), 7.84 (1H, td, J = 7.8 and 1.6, =CH), 7.58-7.48 (2H, m, 2 x 
=CH), 7.46-7.38 (1H, m, =CH), 7.36-7.29 (2H, m, 2 x =CH) , 7.27 (1H, d, J = 8.1, =CH), 6.98-6.87 (2H, m, 2 x 
=CH), 3.83 (2H, s, NHCH2), 3.79 (3H, s, OCH3), 2.18 (3H, s, CH3). 
13C NMR (100 MHz, MeOD) δ = 164.3 (=C), 
164.1 (=C), 159.1 (=C), 151.9 (=CH), 145.5 (=C), 141.5 (=CH), 140.3 (=C), 134.9 (2 x =CH), 133.5 (2 x =CH), 
131.3 (2 x =CH), 128.7 (=C), 127.1 (=CH), 126.0 (=CH), 117.8 (2 x =CH), 70.9 (NC), 58.3 (OCH3), 50.7 (CH2), 
26.8 (CH3). []
  
 
 = -68 (c = 1.00; MeOH). IR (film, cm-1): νmax = 3317, 2947, 2834, 1652, 1253. HRMS (ESI
+): 
m/z calcd for C22H23N2O3 [M+H]
+ 363.1703, found 363.1699. 
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React-IR experiments pictures 
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HPLC data 
8a : CHIRALPAK® AD-H 5 µm LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm 
      
 
 
8b : CHIRALPAK® AD-H 5 µm LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm 
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8c : CHIRALPAK® AD-H 5 µm LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm 
   
 
11a : Phenomenex LUX® 5 µm Amylose-1 LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm 
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11b : Phenomenex LUX® 5 µm Amylose-1 LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm 
 
 
 
11c : Phenomenex LUX® 5 µm Amylose-1 LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm 
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11d : Phenomenex LUX® 5 µm Amylose-1 LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm 
 
 
 
11e : Phenomenex LUX® 5 µm Amylose-1 LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm 
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11f : Phenomenex LUX® 5 µm Amylose-1 LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm 
 
 
 
 
11g : Phenomenex LUX® 5 µm Amylose-1 LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm 
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11h : Phenomenex LUX® 5 µm Amylose-1 LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm 
 
 
13: Phenomenex LUX® 5 µm Amylose-1 LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm 
 
200 mg scale 
 
1.00 g scale 
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14a : CHIRALPAK® AD-H 5 µm LC Column 250 x 4.6 mm, 85:15 hexane-IPA, 1 mL/min, 210 nm 
   
 
14b : CHIRALPAK® AD-H 5 µm LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm
 
At -78 °C : 
  
At -40°C : 
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At –RT : 
 
14c : CHIRALPAK® AD-H 5 µm LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm 
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15a : CHIRALPAK® AD-H 5 µm LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm 
    
 
15b : CHIRALPAK® AD-H 5 µm Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 210.4 nm 
    
N
N
CH3 O
N
H
OCH3
 
 
 
 
 
 
 
 
 
 
119 
 
15c : CHIRALPAK® AD-H 5 µm LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm 
  
 
15d : CHIRALPAK® AD-H 5 µm LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm 
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15e : CHIRALPAK® AD-H 5 µm LC Column 250 x 4.6 mm, 85:15 hexane-IPA, 1 mL/min, 254 nm 
    
 
 
15f : CHIRALPAK® AD-H 5 µm LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 230.4 nm 
  
 
  
121 
 
15g : CHIRALPAK® AD-H 5 µm LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm 
  
 
 
15h : CHIRALPAK® AD-H 5 µm LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 210.4 nm 
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Determination of d.r. in 3aa, and e.r. in the corresponding compounds 17a-d and 7a-d 
To determine the exact diastereomeric ratio in 3a, at a later stage of the synthesis 5a was converted to 7b 
and 7c and the e.r. of the compounds was measured by chiral HPLC. 
Phenomenex LUX® 5 µm Cellulose-3 LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm 
 
 
Phenomenex LUX® 5 µm Cellulose-3 LC Column 250 x 4.6 mm, 90:10 hexane-IPA, 1 mL/min, 254 nm 
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Table 1.  Crystallographic data and structure refinement for compound (R)-11c; the Cambridge Crystallographic Data 
Centre (CCDC) code is 1519696 
Identification code  1519696 
Empirical formula  C16 H18 Cl N3 O 
Formula weight  303.78 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 8.54450(10) Å = 90°. 
 b = 9.1514(2) Å = 90°. 
 c = 19.7296(4) Å  = 90°. 
Volume 1542.74(5) Å3 
Z 4 
Density (calculated) 1.308 Mg/m3 
Absorption coefficient 2.207 mm-1 
F(000) 640 
Crystal size 0.250 x 0.150 x 0.080 mm3 
Theta range for data collection 4.482 to 72.143°. 
Index ranges -10<=h<=10, -11<=k<=11, -23<=l<=17 
Reflections collected 18119 
Independent reflections 3026 [R(int) = 0.0404] 
Completeness to theta = 67.679° 99.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.843 and 0.767605 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3026 / 0 / 197 
Goodness-of-fit on F2 1.040 
Final R indices [I>2sigma(I)] R1 = 0.0247, wR2 = 0.0617 
R indices (all data) R1 = 0.0261, wR2 = 0.0623 
Absolute structure parameter 0.031(6) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.184 and -0.257 e.Å-3 
 
 
